<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30190672</article-id>
<article-id pub-id-type="pmc">6116786</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2018.00265</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Œ≥2 GABA<sub>A</sub>R Trafficking and the Consequences of Human Genetic Variation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lorenz-Guertin</surname>
<given-names>Joshua M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bambino</surname>
<given-names>Matthew J.</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/564765/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacob</surname>
<given-names>Tija C.</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/131314/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: David Perrais, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Christine Laura Dixon, University College London, United Kingdom; Margot Ernst, Medizinische Universit√§t Wien, Austria; Maurice Garret, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<corresp id="c001">*Correspondence: Tija C. Jacob, <email>tcj11@pitt.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>265</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright ¬© 2018 Lorenz-Guertin, Bambino and Jacob.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Lorenz-Guertin, Bambino and Jacob</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>GABA type A receptors (GABA<sub>A</sub>Rs) mediate the majority of fast inhibitory neurotransmission in the central nervous system (CNS). Most prevalent as heteropentamers composed of two Œ±, two Œ≤, and a Œ≥2 subunit, these ligand-gated ionotropic chloride channels are capable of extensive genetic diversity (Œ±1-6, Œ≤1-3, Œ≥1-3, Œ¥, ùúÄ, ùúÉ, œÄ, œÅ1-3). Part of this selective GABA<sub>A</sub>R assembly arises from the critical role for Œ≥2 in maintaining synaptic receptor localization and function. Accordingly, mutations in this subunit account for over half of the known epilepsy-associated genetic anomalies identified in GABA<sub>A</sub>Rs. Fundamental structure‚Äìfunction studies and cellular pathology investigations have revealed dynamic GABA<sub>A</sub>R trafficking and synaptic scaffolding as critical regulators of GABAergic inhibition. Here, we introduce <italic>in vitro</italic> and <italic>in vivo</italic> findings regarding the specific role of the Œ≥2 subunit in receptor trafficking. We then examine Œ≥2 subunit human genetic variation and assess disease related phenotypes and the potential role of altered GABA<sub>A</sub>R trafficking. Finally, we discuss new-age imaging techniques and their potential to provide novel insight into critical regulatory mechanisms of GABA<sub>A</sub>R function.</p>
</abstract>
<kwd-group>
<kwd>GABA<sub>A</sub> receptor</kwd>
<kwd>trafficking</kwd>
<kwd>genetic variation</kwd>
<kwd>human</kwd>
<kwd>epilepsy</kwd>
<kwd>imaging</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Foundation for the National Institutes of Health<named-content content-type="fundref-id">10.13039/100000009</named-content></funding-source>
<award-id rid="cn001">T32GM008424</award-id>
<award-id rid="cn001">R56MH114908-01</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="200"></ref-count>
<page-count count="20"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>The adult central nervous system (CNS) is critically dependent on fast inhibitory neurotransmission evoked by GABA<sub>A</sub> receptors (GABA<sub>A</sub>Rs). GABA<sub>A</sub>Rs are ligand-gated ionotropic chloride (Cl<sup>-</sup>) channels ubiquitously expressed throughout the CNS that play a fundamental role in restraining and sculpting neuronal activity. Disruptions in GABA<sub>A</sub>R dependent neurotransmission leads to insufficient inhibitory effects throughout the brain, contributing to the pathogenesis of epilepsy, neurodevelopmental disorders, depression, schizophrenia and stroke (<xref ref-type="bibr" rid="B64">Hines et al., 2012</xref>). Activation of GABA<sub>A</sub>Rs by the neurotransmitter GABA induces ion channel opening, Cl<sup>-</sup> influx, and subsequent membrane hyperpolarization. These heteropentameric structures are predominantly composed of two Œ± (Œ±1-6), two Œ≤ (Œ≤1-3), and either a Œ≥ (Œ≥1-3) or a Œ¥ subunit (<xref ref-type="bibr" rid="B136">Olsen and Sieghart, 2009</xref>) (<bold>Figures <xref ref-type="fig" rid="F1">1A,B</xref></bold>). GABA<sub>A</sub>Rs belong to the Cys-loop superfamily of pentameric ligand-gated ion channels (pLGICs) including strychnine-sensitive glycine receptors, nicotinic acetylcholine (nACh) receptors, and 5-hydroxytryptamine type-3 (5-HT3) receptors. Individual subunits have a common structure consisting of a large N-terminus extracellular domain (ECD) that participates in endogenous ligand binding, a transmembrane domain (TM) comprised of four Œ±-helical regions (M1-4) and a barely extruding extracellular C-terminus. The M2 region of the subunits forms the ion channel pore. The hydrophobic M regions are connected by a small intracellular loop between M1-M2 and a much larger intracellular domain (ICD; previously termed intracellular loop) between M3 and M4 (<xref ref-type="bibr" rid="B161">Sigel and Steinmann, 2012</xref>) that mediates interactions with intracellular proteins critical for receptor trafficking and synaptic clustering (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>). Recently, GABA<sub>A</sub>R structures for the human Œ≤3 homopentamer bound to benzamidine (<xref ref-type="bibr" rid="B121">Miller and Aricescu, 2014</xref>), chimeric Œ±5TM/Œ≤3ECD bound to the neurosteroid allopregnanolone (<xref ref-type="bibr" rid="B122">Miller et al., 2017</xref>), and human Œ±1Œ≤2Œ≥2 heteropentamer bound to GABA and the benzodiazepine site antagonist Flumazenil (<xref ref-type="bibr" rid="B200">Zhu et al., 2018</xref>) were resolved, advancing our growing understanding of GABA<sub>A</sub>R molecular architecture. Importantly, nearly all pLGIC family structural data lacks the large ICD (<xref ref-type="bibr" rid="B133">Nemecz et al., 2016</xref>) (exception 5-HT3 receptor; <xref ref-type="bibr" rid="B58">Hassaine et al., 2014</xref>), leaving functionally relevant information about this region left undiscovered.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Generic GABA<sub>A</sub>R structure and subunit topology; and regulatory sites of the Œ≥2 intracellular domain (ICD). <bold>(A)</bold> GABA<sub>A</sub>R heteropentamer composed of Œ±Œ≤Œ≥ subunits. Binding of the neurotransmitter GABA (yellow circle) at the Œ±Œ≤ interface triggers ion channel opening and allows the rapid influx of Cl<sup>-</sup> and membrane hyperpolarization in the mature nervous system. <bold>(B)</bold> Extracellular representation of the most prevalent cortical receptor subtype composed of Œ±1Œ≤2Œ≥2 subunits showing all five subunits contributing to the central ion pore and the general binding sites of GABA (yellow circle) and benzodiazepines (BZs) (red square). BZs bind at the interface of an Œ±1/2/3/5 and Œ≥ subunit. <bold>(C)</bold> All subunits have a common topology including an extracellular N-terminal domain (ECD), short C-terminal tail, and four transmembrane regions (M1-4) which compose the transmembrane domain (TM). M2 (blue) contributes to formation of the receptor ion channel pore, while the ICD between M3 and M4 contains sites of phosphorylation and protein interactions that modulate channel function and/or trafficking. The Œ≥2 L isoform intracellular domain (ICD = AA 318-404, residue numbering does not include signal peptide) is shown here with identified regulatory sites and regions of protein interaction. Seven lysine residues (red) contribute to Œ≥2-containing GABA<sub>A</sub>R ubiquitination and endo-lysosomal targeting in HEK cells, with mutation of three additional lysine residues needed to block receptor downregulation by E3 ligase RNF34 overexpression (ICD green Ks and K259 in smaller M1-M2 loop not shown in diagram). Note the Œ≥2L specific K344 residue (brown) has not been tested in ubiquitination studies <bold>(D)</bold> GABA<sub>A</sub>Rs composed of Œ±(1-3)Œ≤Œ≥ subunits are largely synaptically localized via gephyrin interactions and contribute to phasic currents, whereas Œ±(4 or 6)Œ≤Œ¥ receptors are extrasynaptic and generate tonic current.</p>
</caption>
<graphic xlink:href="fncel-12-00265-g001"></graphic>
</fig>
<p>Presynaptic terminal release of GABA onto postsynaptically clustered GABA<sub>A</sub>Rs initiates fast, transient receptor activation. In contrast, activation of extrasynaptic GABA<sub>A</sub>Rs by ambient ‚Äúspill over‚Äù GABA generates a persistent tonic current (<bold>Figure <xref ref-type="fig" rid="F1">1D</xref></bold>). Most GABA<sub>A</sub>Rs evoking fast synaptic inhibition in the mature cortex contain Œ±1Œ≤2Œ≥2 subunits, although Œ±/Œ≤ content can vary widely (<xref ref-type="bibr" rid="B136">Olsen and Sieghart, 2009</xref>), prompting a unifying role of Œ≥2 in synaptic function. Importantly, the benzodiazepine drug class selectively binds between the interface of a Œ≥2 subunit and either an Œ±1/2/3/5 subunit to potentiate GABA<sub>A</sub>R function and elicit behavioral effects including sedative/hypnotic, anti-convulsant, myorelaxant, and/or anti-anxiety effects (<xref ref-type="bibr" rid="B183">Vinkers and Olivier, 2012</xref>) (<bold>Figures <xref ref-type="fig" rid="F1">1A,B</xref></bold>). Here we summarize (1) known molecular interactors and mechanisms regulating Œ≥2 trafficking (2) the importance of this subunit physiologically and human Œ≥2 genetic variants compromising structure and function <italic>in vitro</italic> and <italic>in vivo</italic> and (3) application of modern imaging techniques to discover novel insight into synaptic GABA<sub>A</sub>R modulation.</p>
</sec>
<sec>
<title>Œ≥2 Subunit Trafficking and Interactors</title>
<sec>
<title>Biosynthetic Trafficking and Insertion</title>
<p>During biosynthesis, GABA<sub>A</sub>R subunits are first assembled in the endoplasmic reticulum (ER) and then transported to the Golgi apparatus (Golgi) for further maturation (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Forward trafficking of Œ≥2-GABA<sub>A</sub>Rs from the ER is negatively regulated by Cleft lip and palate transmembrane protein (CLPTM1) <italic>in vitro</italic> and <italic>in vivo</italic> (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B43">Ge et al., 2018</xref>). Overexpressing CLPTM1 reduces surface and synaptic levels of Œ≥2, resulting in reduced amplitude and frequency of inhibitory postsynaptic current (IPSC), where the opposite effect is seen by CLPTM1 knockdown (KD). Importantly, CLPTM1 also regulates tonic inhibition and interacts with the extrasynaptic subunits Œ±4 and Œ¥, suggesting this protein non-selectively binds many GABA<sub>A</sub>R subtypes. Upon entry into the Golgi, the Œ≥2 subunit undergoes palmitoylation via the Golgi-specific DHHC zinc finger enzyme (GODZ; also known as ZDHHC3) (<xref ref-type="bibr" rid="B88">Keller et al., 2004</xref>; <xref ref-type="bibr" rid="B37">Fang et al., 2006</xref>). This process is key for receptor clustering, innervation, and inhibitory strength <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B88">Keller et al., 2004</xref>; <xref ref-type="bibr" rid="B37">Fang et al., 2006</xref>; <xref ref-type="bibr" rid="B89">Kilpatrick et al., 2016</xref>). GABA<sub>A</sub>R forward trafficking to the cell surface depends on the microtubule-dependent molecular motor kinesins (KIFs) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). The KIF21B protein co-precipitates with the GABA<sub>A</sub>R Œ≥2 subunit (<xref ref-type="bibr" rid="B96">Labonte et al., 2014</xref>). RNA KD of KIF21B reduces receptor surface levels and the intensity of extrasynaptic Œ≥2 clusters, but does not affect synaptic GABA<sub>A</sub>Rs levels. Additionally, the KIF5 family plays a critical role in trans-Golgi to surface GABA<sub>A</sub>R trafficking (<xref ref-type="bibr" rid="B180">Twelvetrees et al., 2010</xref>). Conditional knockout (KO) of KIF5A in mice results in deficits of GABA<sub>A</sub>R plasma membrane levels, epilepsy phenotypes, and high lethality rate within 21 days postnatal (<xref ref-type="bibr" rid="B129">Nakajima et al., 2012</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>GABA<sub>A</sub>R trafficking and key interacting proteins at GABAergic synapses. The process of GABA<sub>A</sub>R synthesis, assembly and forward trafficking is highly regulated. Forward trafficking of Œ≥2-GABA<sub>A</sub>Rs from the ER is negatively regulated by CLPTM1. Subunits are assembled into pentameric receptors in the endoplasmic reticulum (ER) where proper folding allows receptors to avoid proteosomal degradation and exit to the Golgi. In the Golgi, palmitoylation of Œ≥ subunits by the palmitoyltransferase GODZ is a key step in promoting forward trafficking to the synapse. GABARAP interacts with Œ≥ subunits and microtubules and overexpression augments receptor plasma membrane levels. PX-RICS forms an adaptor complex with GABARAP to facilitate Œ≥2-GABA<sub>A</sub>Rs forward trafficking. PRIP1/2 and NSF interact with GABA<sub>A</sub>Rs both indirectly via GABARAP and directly with Œ≤ subunits. The kinesin KIF5 is the main microtubule (MT)-dependent motor transporting inhibitory synapse components although recent work shows KIF21 contributes to extrasynaptic receptor delivery. LH4 forms a complex between Œ≥2 and NL2. NL2 is central in GABA<sub>A</sub>R synapse development via its trans-synaptic association with axonal neurexins and also binds gephyrin. GABA<sub>A</sub>Rs primarily undergo clathrin-dependent endocytosis via Œ≤ and Œ≥ subunit interactions with the clathrin-adaptor protein 2 (AP2) complex. Phosphorylation of AP2-interaction motifs within receptor subunits increases cell-surface receptor levels and enhances GABA<sub>A</sub>R neurotransmission by reducing AP2 binding to receptors. After internalization, clathrin-coated vesicles fuse with early endosomes, allowing for subsequent receptor recycling or targeting for degradation in lysosomes. CAML interaction with the Œ≥2 subunit promotes forward trafficking and recycling. Ubiquitination of GABA<sub>A</sub>R contributes to lysosomal targeting, with the ubiquitin E3 ligase RNF34 directly interacting with the Œ≥2 subunit. Protein abbreviations: CAML (calcium-modulating cyclophilin ligand), CLPTM1 (Cleft lip and palate transmembrane protein), GABARAP (GABAAR - associated protein), GODZ (Golgi-specific DHHC zinc finger enzyme), KIF 5/21 (microtubule-dependent molecular motor kinesins), LH4 (lipoma HMGIC fusion partner-like protein 4), NL2 (neuroligin 2), NSF (<italic>N</italic>-ethylmaleimide-sensitive factor ATPase), PRIP (phospholipase C-related catalytically inactive proteins), PX-RICS [Rho GTPase Activating Protein 32 (ARHGAP32) isoform 1], RNF34 (ring finger protein 34 E3 ligase).</p>
</caption>
<graphic xlink:href="fncel-12-00265-g002"></graphic>
</fig>
<p>Notably, KIF5A (not KIF5B, KIF5C) selectively interacts with the GABA<sub>A</sub>R-associated protein (GABARAP) <italic>in vivo</italic> (<xref ref-type="bibr" rid="B129">Nakajima et al., 2012</xref>). The well-characterized GABARAP (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) is part of the ubiquitin-like protein (UBL) family implicated in numerous cellular processes (<xref ref-type="bibr" rid="B182">van der Veen and Ploegh, 2012</xref>). GABARAP interacts with GABA<sub>A</sub>R Œ≥ subunits and microtubules, is heavily localized at the Golgi apparatus and cell surface (<xref ref-type="bibr" rid="B187">Wang et al., 1999</xref>), and overexpression augments GABA<sub>A</sub>R plasma membrane levels (<xref ref-type="bibr" rid="B99">Leil et al., 2004</xref>). However, GABARAP KO mice have unhindered distribution of Œ≥2-GABA<sub>A</sub>Rs and gephyrin, suggesting functional redundancy with other trafficking proteins (<xref ref-type="bibr" rid="B137">O‚ÄôSullivan et al., 2005</xref>). Some evidence suggests GABARAP preferentially associates with serine phosphorylated Œ≥2-GABA<sub>A</sub>Rs, while dephosphorylation by protein phosphatase 1 (PP1) decreases this interaction (<xref ref-type="bibr" rid="B144">Qian et al., 2011</xref>).</p>
<p>A number of GABARAP interacting proteins mediate GABA<sub>A</sub>R trafficking or localization (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). For instance, increased association with the PDZ domain-containing protein GRIP is seemingly involved in NMDA receptor-dependent GABA<sub>A</sub>R synaptic plasticity (<xref ref-type="bibr" rid="B114">Marsden et al., 2007</xref>). The phospholipase C-related catalytically inactive proteins 1 and 2 (PRIP1/2) and the <italic>N</italic>-ethylmaleimide-sensitive factor ATPase (NSF) interact with GABA<sub>A</sub>Rs both indirectly via GABARAP and directly with Œ≤ subunits (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B80">Kanematsu et al., 2002</xref>; <xref ref-type="bibr" rid="B172">Terunuma et al., 2004</xref>; <xref ref-type="bibr" rid="B49">Goto et al., 2005</xref>; <xref ref-type="bibr" rid="B123">Mizokami et al., 2007</xref>). NSF is a key component of SNARE-mediated fusion and is involved in receptor cell surface transit (<xref ref-type="bibr" rid="B25">Chou et al., 2010</xref>). Notably, the Œ≥2 subunit and PRIP share an overlapping binding site on GABARAP (<xref ref-type="bibr" rid="B80">Kanematsu et al., 2002</xref>). PRIP1/2 KO mice demonstrate diminished benzodiazepine sensitivity and Zn<sup>2+</sup> modulation concurrent with lower plasma membrane GABA<sub>A</sub>R expression, consistent with impaired Œ≥2 subunit trafficking. KO of PRIP-1, the primary brain subtype, leads to mice displaying an epileptic phenotype that can be successfully suppressed by diazepam (DZP), but interictal discharges persist (<xref ref-type="bibr" rid="B199">Zhu et al., 2012</xref>). Interestingly, DZP potentiation of miniature inhibitory postsynaptic currents (mIPSC) remains unchanged, but baseline and DZP potentiated tonic GABA current amplitude in PRIP-1 KO neurons was reduced. PRIP-1 KO and PRIP1/2 double KO mice show anxiety-related behaviors and abnormal locomotion related to GABA<sub>A</sub>R dysfunction and reduced benzodiazepine sensitivity. Recently the Rho GTPase Activating Protein 32 (ARHGAP32) isoform 1 (PX-RICS) was shown to form an adaptor complex with GABARAP and the scaffold proteins 14-3-3Œ∂/ùúÉ to facilitate Œ≥2-GABA<sub>A</sub>Rs forward trafficking via dynein/dynactin and promote surface expression (<xref ref-type="bibr" rid="B130">Nakamura T. et al., 2016</xref>). KO of <italic>PX-RICS</italic> in mice generates an Autism Spectrum Disorder (ASD) phenotype with increased susceptibility to kainate-induced epileptic seizures, decreased GABA<sub>A</sub>R plasma membrane levels, and lowered mIPSC amplitude. Transgenic overexpression of 14-3-3Œ∂ in mice protects against neuronal death caused by prolonged seizures (<xref ref-type="bibr" rid="B18">Brennan et al., 2013</xref>). In contrast, 14-3-3Œ∂ mutations or deletions have been identified in patients with pathology associated with GABA<sub>A</sub>R deficits including schizophrenia, autism and generalized epilepsy (<xref ref-type="bibr" rid="B171">Tenney et al., 2011</xref>; <xref ref-type="bibr" rid="B41">Fromer et al., 2014</xref>; <xref ref-type="bibr" rid="B175">Toma et al., 2014</xref>).</p>
</sec>
<sec>
<title>Synaptic Accumulation and Functional Regulation</title>
<p>Following insertion at the plasma membrane, Œ≥2-GABA<sub>A</sub>Rs undergo Brownian diffusion until interaction with the inhibitory postsynaptic scaffolding protein gephyrin causes constraint and accumulation (<bold>Figures <xref ref-type="fig" rid="F1">1D</xref>, <xref ref-type="fig" rid="F2">2</xref></bold>). Specifically, GABA<sub>A</sub>R Œ±1/2/3/5 and Œ≤2/3 subunits (at lower affinity) mediate gephyrin-receptor binding (<xref ref-type="bibr" rid="B176">Tretter et al., 2008</xref>, <xref ref-type="bibr" rid="B177">2011</xref>; <xref ref-type="bibr" rid="B128">Mukherjee et al., 2011</xref>; <xref ref-type="bibr" rid="B95">Kowalczyk et al., 2013</xref>; <xref ref-type="bibr" rid="B14">Brady and Jacob, 2015</xref>). While no direct interaction between Œ≥2 and gephyrin has been identified, the synaptic levels of these proteins are intimately tied, shown by KO studies of gephyrin (<xref ref-type="bibr" rid="B94">Kneussel et al., 1999</xref>) and Œ≥2 (<xref ref-type="bibr" rid="B154">Schweizer et al., 2003</xref>). Interestingly, chimeric studies indicate the Œ≥2 M4 is sufficient to cause GABA<sub>A</sub>R accumulation opposite GABAergic terminals, while the large ICD of Œ≥2 is necessary for gephyrin recruitment and rescue of synaptic function in Œ≥2 KO cultured neurons (<xref ref-type="bibr" rid="B1">Alldred et al., 2005</xref>). It is likely that an indirect interaction occurs between Œ≥2 and gephyrin across a bridge of other key synaptic proteins. Recently, six unrelated patients were identified with microdeletions in the gephyrin gene resulting in a range of neurodevelopmental deficits including ASD, schizophrenia or epilepsy (<xref ref-type="bibr" rid="B107">Lionel et al., 2013</xref>). The recently discovered GABA<sub>A</sub>R regulatory Lhfpl (GARLH) family proteins lipoma HMGIC fusion partner-like 3 and 4 (LH3 and LH4) forms a native complex between Œ≥2 and the transsynaptic protein neuroligin 2 (NL2) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B195">Yamasaki et al., 2017</xref>). NL2 is central in GABA<sub>A</sub>R synapse development via its trans-synaptic association with axonal neurexins (<xref ref-type="bibr" rid="B167">Sudhof, 2008</xref>). Diminishing LH4 levels in culture and <italic>in vivo</italic> dramatically reduced Œ≥2-GABA<sub>A</sub>R and gephyrin synaptic clustering and inhibitory strength (<xref ref-type="bibr" rid="B29">Davenport et al., 2017</xref>; <xref ref-type="bibr" rid="B195">Yamasaki et al., 2017</xref>). Curiously, despite the dramatic reduction in synaptic inhibition, epilepsy susceptibility or overt behavioral phenotypes in these mice have yet to be reported in the constitutive LH4 KO mouse. Importantly, gephyrin is known to directly bind the intracellular domain of NL2 (<xref ref-type="bibr" rid="B141">Poulopoulos et al., 2009</xref>). Thus Œ≥2 subunit-LH4-NL2-gephyrin interactions could provide a molecular framework to support Œ≥2‚Äôs role in GABA<sub>A</sub>R synaptic recruitment and maintenance.</p>
<p>Synaptic plasticity, or the dynamic modulation of synaptic output, is heavily influenced by receptor phosphorylation via altering channel function or receptor trafficking. Phosphoregulation of Œ≥2 S327 is an important mediator of GABA<sub>A</sub>R retention at synapses. Detailed electrophysiology and <italic>in vivo</italic> studies have identified the PKCùúÄ isoform specifically phosphorylates the Œ≥2 S327 residue (<bold>Figures <xref ref-type="fig" rid="F1">1C</xref>, <xref ref-type="fig" rid="F2">2</xref></bold>), ultimately fine-tuning responsiveness to ethanol and benzodiazepines (<xref ref-type="bibr" rid="B142">Qi et al., 2007</xref>). Additionally, protocols that induce calcium-entry via glutamate application, strong NMDA receptor activation, or robust neuronal activity enhance receptor lateral mobility, decrease synaptic cluster size, and reduce mIPSC amplitude via the phosphatase calcineurin (CaN) (<xref ref-type="bibr" rid="B3">Bannai et al., 2009</xref>) and dephosphorylation of the Œ≥2 subunit S327 residue (<bold>Figures <xref ref-type="fig" rid="F1">1C</xref>, <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B126">Muir et al., 2010</xref>). More broadly, activation of all PKC isoforms by 1 h PMA (PKC activator; 30 nM) treatment decreases surface Œ≥2-GABA<sub>A</sub>R levels that can be reversed by specific inhibition of PKCùúÄ catalytic activity in HEK cells and PKCùúÄ specific activation reduces GABA<sub>A</sub>R current amplitude (<xref ref-type="bibr" rid="B25">Chou et al., 2010</xref>). This effect was in part attributed to changes in GABA<sub>A</sub>R trafficking occurring though PKCùúÄ association and phosphorylation of NSF. The scaffolding protein 14-3-3-ùúÉ acts as a bridge for the PKCŒ≥ isoform to interact with Œ≥2 in cerebellar Purkinje neurons and N2a cells (<xref ref-type="bibr" rid="B143">Qian et al., 2012</xref>). 14-3-3-ùúÉ KD in mice by siRNA microinjection reduces Œ≥2-GABA<sub>A</sub>R overall serine phosphorylation, while KD of 14-3-3-ùúÉ or PKCŒ≥ reverses the PMA (200 nM, 30 min) induced upregulation of C cell surface expression in N2a cells. These apparently conflicting reports on PKC kinase family modulation highlights the complexity of this signaling pathway in Œ≥2-GABA<sub>A</sub>R regulation, with varied effects dependent on the pharmacological agents used, treatment times, model, and PKC isoforms.</p>
<p>An important consideration for Œ≥2 subunit regulation is its presence in a short (Œ≥2S) or long (Œ≥2L) isoform; the Œ≥2L isoform has 8 additional amino acids (LLRMFSFK) in the large ICD with the serine site (S343) capable of being phosphorylated by Protein kinase C (PKC) and Calcium/calmodulin-dependent protein kinase type II (CaMKII) (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>) (<xref ref-type="bibr" rid="B191">Whiting et al., 1990</xref>; <xref ref-type="bibr" rid="B124">Moss et al., 1992</xref>; <xref ref-type="bibr" rid="B118">McDonald and Moss, 1994</xref>). Expression levels of Œ≥2S remain constant throughout development, while Œ≥2L levels increase during neuronal maturation (<xref ref-type="bibr" rid="B189">Wang and Burt, 1991</xref>). Early <italic>in vitro</italic> expression studies found that the additional amino acids in the Œ≥2L subunit may play a role in the response to diazepam and be critical for ethanol enhancement of GABA current (<xref ref-type="bibr" rid="B185">Wafford et al., 1991</xref>). Both mutation of S343 to a phosphomimetic aspartate or to non-phosphorylatable valine resulted in cell surface trafficking of Œ≥2L when expressed alone, similar to Œ≥2S (<xref ref-type="bibr" rid="B10">Boileau et al., 2010</xref>). This work also proposed an accessory protein role for Œ≥2S as an external modulator of GABA<sub>A</sub>R function to confer zinc blockade protection for receptors. When comparing synaptic clustering of Œ≥2L vs. Œ≥2S subunit large ICD (partial subunit chimeras) in spinal cord neurons, postsynaptic Œ≥2L ICD chimera accumulation is higher, and can be enhanced by PKC activation by phorbol ester phorbol-12,13-dibutyrate (PDBu) and reversed by mutating the S343 residue of Œ≥2L (<xref ref-type="bibr" rid="B119">Meier and Grantyn, 2004</xref>). The physiological role of CaMKII direct phosphorylation on Œ≥2 has not yet been described, although CaMKII is required for a type of inhibitory long term potentiation (iLTP) in Purkinje neurons known as rebound potentiation (<xref ref-type="bibr" rid="B86">Kano et al., 1996</xref>) and increased association between the Œ≥2 subunit and GABARAP (<xref ref-type="bibr" rid="B87">Kawaguchi and Hirano, 2007</xref>). CaMKII plays other critical roles in GABAergic plasticity including promoting receptor surface levels (<xref ref-type="bibr" rid="B190">Wang et al., 1995</xref>; <xref ref-type="bibr" rid="B114">Marsden et al., 2007</xref>, <xref ref-type="bibr" rid="B115">2010</xref>; <xref ref-type="bibr" rid="B151">Saliba et al., 2012</xref>) and recruitment of the synaptic scaffold protein gephyrin, while reducing GABA<sub>A</sub>R lateral diffusion (<xref ref-type="bibr" rid="B140">Petrini et al., 2014</xref>).</p>
</sec>
<sec>
<title>Internalization</title>
<p>Non-synaptic GABA<sub>A</sub>Rs on the cell surface are capable of undergoing internalization (<xref ref-type="bibr" rid="B9">Bogdanov et al., 2006</xref>), a fundamental cellular process that regulates receptor signaling and function (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). GABA<sub>A</sub>R internalization is primarily clathrin-mediated in concert with GTPase dynamin activity and the adaptor protein AP2 complex (<xref ref-type="bibr" rid="B92">Kittler et al., 2000</xref>), although clathrin-independent GABA<sub>A</sub>R endocytosis has been described (<xref ref-type="bibr" rid="B26">Cinar and Barnes, 2001</xref>; <xref ref-type="bibr" rid="B150">Rowland et al., 2006</xref>). AP2 interacts with the ICD of GABA<sub>A</sub>R Œ≤ subunits and the extrasynaptic Œ¥ subunit in a phospho-dependent manner (<xref ref-type="bibr" rid="B117">McDonald et al., 1998</xref>; <xref ref-type="bibr" rid="B15">Brandon et al., 2002</xref>, <xref ref-type="bibr" rid="B17">2003</xref>; <xref ref-type="bibr" rid="B63">Herring et al., 2005</xref>; <xref ref-type="bibr" rid="B90">Kittler et al., 2005</xref>; <xref ref-type="bibr" rid="B164">Smith et al., 2008</xref>; <xref ref-type="bibr" rid="B46">Gonzalez et al., 2012</xref>; <xref ref-type="bibr" rid="B165">Smith et al., 2012</xref>). The Œ≥2 subunit also contains two AP2 interaction domains on its ICD, a 12 basic amino acid region and a classical YGYECL motif (<xref ref-type="bibr" rid="B164">Smith et al., 2008</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>). Phosphorylation at Y365/367 residues within the YGYECL motif by the non-receptor tyrosine-protein kinases Fyn and Src family kinases (<xref ref-type="bibr" rid="B125">Moss et al., 1995</xref>; <xref ref-type="bibr" rid="B16">Brandon et al., 2001</xref>; <xref ref-type="bibr" rid="B78">Jurd et al., 2010</xref>) reduces AP2 binding, as does mutation of Y365/7 to phenylalanine (<xref ref-type="bibr" rid="B91">Kittler et al., 2008</xref>; <xref ref-type="bibr" rid="B178">Tretter et al., 2009</xref>). Homozygous tyrosine to phenylalanine (Y365/7F) knock-in mice are developmentally lethal, suggesting phosphoregulation of these residues is critical for GABA<sub>A</sub>R function or trafficking <italic>in vivo</italic>. Heterozygous Y365/7F knock-in mutant mice show inhibition of AP2 binding to the Œ≥2 subunit, surface and synaptic accumulation of receptors and ultimately spatial memory deficits (<xref ref-type="bibr" rid="B178">Tretter et al., 2009</xref>). Further investigation revealed that brain-derived neurotrophic factor (BDNF) enhances Y365/7 phosphorylation and stabilizes Œ≥2-containing GABA<sub>A</sub>R, consistent with heterozygous Y365/7F mice showing an anti-depressant phenotype in the forced swim task and tail-suspension test and increased neurogenesis effects that are resistant to further enhancement by BDNF (<xref ref-type="bibr" rid="B184">Vithlani et al., 2013</xref>).</p>
<p>GABA<sub>A</sub>R endocytosis can be increased by stimuli of opposite polarities, either excitotoxic protocols such as <italic>in vitro</italic> seizure (<xref ref-type="bibr" rid="B48">Goodkin et al., 2005</xref>, <xref ref-type="bibr" rid="B47">2008</xref>; <xref ref-type="bibr" rid="B132">Naylor et al., 2005</xref>; <xref ref-type="bibr" rid="B109">Lorenz-Guertin et al., 2017</xref>) and oxygen-glucose deprivation (OGD) (<xref ref-type="bibr" rid="B2">Arancibia-Carcamo et al., 2009</xref>), or by prolonged inhibition with agonist exposure (<xref ref-type="bibr" rid="B23">Chaumont et al., 2013</xref>; <xref ref-type="bibr" rid="B56">Gutierrez et al., 2014</xref>). Internalization is in part regulated by phosphatase activity under these conditions. For example, inhibition of CaN or the serine/threonine protein phosphatase 1 (PP1) and 2A (PP2A) reverses a status epilepticus induced decrease in surface Œ≥2-GABA<sub>A</sub>Rs and mIPSC amplitude (<xref ref-type="bibr" rid="B77">Joshi et al., 2015</xref>). Importantly, genetic GABA<sub>A</sub>R mutants also affect intracellular trafficking. For instance, the Œ≥2 R82Q (numbering without signal peptide R43Q) mutation linked to childhood absence epilepsy and febrile seizures (FS) showed increased basal receptor endocytosis rates relative to wild-type (<xref ref-type="bibr" rid="B23">Chaumont et al., 2013</xref>). In summary, endogenous signaling pathways, pharmacological treatments, and pathological stimuli or genetic variation can modulate GABA<sub>A</sub>R endocytosis networks [kinase and phosphatase regulation reviewed in <xref ref-type="bibr" rid="B108">Lorenz-Guertin and Jacob (2017)</xref>].</p>
</sec>
<sec>
<title>Recycling/Lysosomal Degradation</title>
<p>Internalized GABA<sub>A</sub>Rs can either be recycled back to the cell surface or targeted for degradation at lysosomes (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B93">Kittler et al., 2004</xref>; <xref ref-type="bibr" rid="B2">Arancibia-Carcamo et al., 2009</xref>). Interaction of the integral membrane protein calcium-modulating cyclophilin ligand (CAML) with the Œ≥2 subunit cytoplasmic and fourth transmembrane domain regions promotes forward trafficking and recycling (<xref ref-type="bibr" rid="B196">Yuan et al., 2008</xref>). Neurons lacking CAML demonstrate diminished recycling of endocytosed GABA<sub>A</sub>Rs and decreased inhibitory strength. Broad PKC activity is implicated as a negative regulator of GABA<sub>A</sub>R recycling activity following internalization (<xref ref-type="bibr" rid="B27">Connolly et al., 1999</xref>). 5-HT2 serotonergic negative modulation of GABA<sub>A</sub>R currents is also thought to occur through a PKC-RACK1 (receptor for activated C kinase) mechanism (<xref ref-type="bibr" rid="B38">Feng et al., 2001</xref>).</p>
<p>Synaptic receptors destined for degradation undergo ubiquitination of 7 lysine residues within the ICD of the Œ≥2 subunit (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>) (<xref ref-type="bibr" rid="B2">Arancibia-Carcamo et al., 2009</xref>). Lysine to arginine (K7R) mutation at these ubiquitination sites diminishes late endosome targeting of receptors in heterologous cells, and reverses loss of surface receptor clusters following OGD treatment (<xref ref-type="bibr" rid="B2">Arancibia-Carcamo et al., 2009</xref>). The ring finger protein 34 (RNF34) E3 ligase directly binds the Œ≥2 ICD, co-immunoprecipitates with Œ≥2 <italic>in vivo</italic> and can be identified at inhibitory synapses (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>) (<xref ref-type="bibr" rid="B75">Jin et al., 2014</xref>). Interestingly, the short 14 amino acid motif in the Œ≥2 ICD sufficient for RNF34 binding is identical to the GODZ binding region (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>), and is also highly conserved among the Œ≥ subunits. Œ≥2-GABA<sub>A</sub>R degradation is accelerated upon overexpression of RNF34 resulting in smaller GABA<sub>A</sub>R synaptic clusters and diminished inhibitory current strength. Proteosomal and lysosomal inhibitor experiments suggest RNF34 ubiquitination of Œ≥2 contributes to degradation by both of these pathways in HEK cells. Notably, co-expression of RNF34 with the Œ≥2 ubiquitin resistant K7R mutant did not inhibit degradation of this subunit. On the contrary, additional lysine mutations (K8R, K9R, K10R) were able to prevent downregulation of Œ≥2 by RNF34, suggesting these residues may be important for ubiquitination-degradation.</p>
<p>Only a handful of stimuli clearly induce lysosomal degradation of GABA<sub>A</sub>Rs, likely due to the receptor‚Äôs crucial role in maintaining neuronal inhibition and the tight regulation of receptor surface levels that must therefore occur. Our lab previously found 24 h benzodiazepine treatment in cultured hippocampal neurons enhances lysosomal-mediated degradation of Œ±2-containing receptors (<xref ref-type="bibr" rid="B73">Jacob et al., 2012</xref>). More recently, we identified that a GABA<sub>A</sub>R antagonist bicuculline acute seizure model also induces lysosomal targeting of surface GABA<sub>A</sub>Rs in cultured cortical neurons (<xref ref-type="bibr" rid="B109">Lorenz-Guertin et al., 2017</xref>). It is likely that stimulus specific subunit ubiquitination patterns ultimately dictate receptor fate. This remains a highly understudied area of research in GABA<sub>A</sub>R trafficking.</p>
</sec>
<sec>
<title>Proteomics</title>
<p>The network of proteins governing inhibitory synapse clustering, trafficking, and plasticity are unresolved, as evidenced by three recent <italic>in vivo</italic> inhibitory synapse proteomic screenings utilizing either knock-in mice expressing GFP-tagged Œ±2 subunit (<xref ref-type="bibr" rid="B131">Nakamura Y. et al., 2016</xref>), adeno-associated viral (AAV) expression of fusion proteins including gephyrin (<xref ref-type="bibr" rid="B181">Uezu et al., 2016</xref>), or mice expressing a Thy1-His6-Flag-YFP-Œ≥2 subunit transgene (<xref ref-type="bibr" rid="B43">Ge et al., 2018</xref>). Initial analysis from these experiments has revealed novel inhibitory protein constituents including the metabotropic glutamate receptor subunit mGluR5, the Dbl family GEF Ephexin, metabotropic GABA B receptor (GABA<sub>B</sub>R) auxiliary subunit KCTD12, and inhibitory synaptic regulator protein 1 (InSyn1) (<xref ref-type="bibr" rid="B131">Nakamura Y. et al., 2016</xref>; <xref ref-type="bibr" rid="B181">Uezu et al., 2016</xref>). Most recently, tandem affinity purification proteomics revealed the critical GABA<sub>A</sub>R forward trafficking component CLPTM1, and two novel interactors including integral membrane protein 2C (ITM2C) and Golgi glycoprotein 1 (GLG1) (<xref ref-type="bibr" rid="B43">Ge et al., 2018</xref>). Considering new candidate interactor proteins are identified with slight derivations in methodology (140 in <xref ref-type="bibr" rid="B181">Uezu et al., 2016</xref>; 149 in <xref ref-type="bibr" rid="B131">Nakamura Y. et al., 2016</xref>; 39 additional in <xref ref-type="bibr" rid="B43">Ge et al., 2018</xref>), future investigations will need to both confirm the validity and importance of these observed proteins in GABA<sub>A</sub>R function and modulation.</p>
</sec>
<sec>
<title>Genetic Knockdown and Knockout of Œ≥2 in Rodents</title>
<p>Due to the fundamental importance of Œ≥2 GABA<sub>A</sub>R inhibition in the CNS, embryonic KO animals die within days of birth (<xref ref-type="bibr" rid="B55">Gunther et al., 1995</xref>). Developmentally delayed KO of Œ≥2 using a CaMKIICre transgene expression system results in mice who are phenotypically normal 3 weeks post-natal, but by week 4 exhibit a rapid decline in health including epileptic episodes and eventually death (<xref ref-type="bibr" rid="B154">Schweizer et al., 2003</xref>). A large drop in gephyrin immunoreactivity also occurs coincident with loss of Œ≥2 expression without changing GABAergic presynaptic innervation as measured by vesicular inhibitory amino acid transporter (VIAAT) levels.</p>
<p>Partial KD of brain wide Œ≥2 levels results in impaired behavior including an enhanced anxious-depressive phenotype (<xref ref-type="bibr" rid="B28">Crestani et al., 1999</xref>; <xref ref-type="bibr" rid="B22">Chandra et al., 2005</xref>; <xref ref-type="bibr" rid="B34">Earnheart et al., 2007</xref>; <xref ref-type="bibr" rid="B157">Shen et al., 2010</xref>). In addition, heterozygous Œ≥2<sup>+/-</sup> mice show defective spine maturation and synaptogenesis (<xref ref-type="bibr" rid="B148">Ren et al., 2015</xref>). Ablating forebrain Œ≥2 expression in embryonic glutamatergic neurons using homozygous EMX1Cre-induced inactivation also recapitulated the depressive-anxiety phenotype and reduced hippocampal neurogenesis similar to total heterozygous Œ≥2 KO mice (<xref ref-type="bibr" rid="B34">Earnheart et al., 2007</xref>). In contrast, KD of Œ≥2 in neurons at post-natal day 13/14 did not affect hippocampal neurogenesis, but anxiety- and depressive-like behavior still formed (<xref ref-type="bibr" rid="B156">Shen et al., 2012</xref>). Numerous studies have examined brain-region or cell-type specific Œ≥2 KD or KO describing circuit specific roles that will not be discussed here (<xref ref-type="bibr" rid="B19">Buhr et al., 1997</xref>; <xref ref-type="bibr" rid="B192">Wingrove et al., 1997</xref>; <xref ref-type="bibr" rid="B193">Wulff et al., 2007</xref>, <xref ref-type="bibr" rid="B194">2009</xref>; <xref ref-type="bibr" rid="B98">Lee et al., 2010</xref>; <xref ref-type="bibr" rid="B103">Leppa et al., 2011</xref>, <xref ref-type="bibr" rid="B102">2016</xref>; <xref ref-type="bibr" rid="B197">Zecharia et al., 2012</xref>; <xref ref-type="bibr" rid="B166">Stojakovic et al., 2018</xref>).</p>
<p>Homozygous deletion of Œ≥2L in mice results in near complete replacement with Œ≥2S subunit (<xref ref-type="bibr" rid="B66">Homanics et al., 1999</xref>). When examining Œ≥2 isoform specific ablation, <italic>in vitro</italic> findings (refer to earlier discussion in Synaptic Accumulation and Functional Regulation) would suggest GABA<sub>A</sub>R incorporating Œ≥2L vs. Œ≥2S would incur distinct changes in functional and pharmacological properties of GABA<sub>A</sub>R. Yet, this isoform switch did not result in changed responsiveness to ethanol in behavioral or electrophysiology experiments, although a mild increase in anxiety was observed (<xref ref-type="bibr" rid="B66">Homanics et al., 1999</xref>). Interestingly, the Œ≥2L <sup>-/-</sup> mice did show a modest increase in behavioral sensitivity and GABA<sub>A</sub>R affinity for benzodiazepine agonists (<xref ref-type="bibr" rid="B145">Quinlan et al., 2000</xref>). Isoform switching of Œ≥2 <italic>in vivo</italic> has been described to occur in response to certain cues such as chronic intermittent ethanol administration in rats (<xref ref-type="bibr" rid="B139">Petrie et al., 2001</xref>; <xref ref-type="bibr" rid="B20">Cagetti et al., 2003</xref>) and in schizophrenic brains of humans (<xref ref-type="bibr" rid="B70">Huntsman et al., 1998</xref>). The relevance of Œ≥2 isoform switching and predominance to pathophysiology <italic>in vivo</italic> remains poorly understood.</p>
</sec>
</sec>
<sec>
<title>Human Genetic Variation of Œ≥2 and Pathological Implications</title>
<sec>
<title>Pathology Arises From Œ≥2 Genetic Anomalies in Humans</title>
<p>Amongst all the subunit genes, mutations in <italic>GABRG2</italic> encoding the Œ≥2 subunit are most commonly linked to epileptogenesis (<xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>). Indeed, heterozygous Œ≥2 R82Q mutant mice were one of the first <italic>in vivo</italic> models for childhood absence epilepsy, recapitulating a familial mutation phenotype including onset, behavior, and treatment responsiveness (<xref ref-type="bibr" rid="B170">Tan et al., 2007</xref>). <italic>GABRG2</italic> genetic anomalies including missense, nonsense, frameshift, splice-site, insertion and deletion mutations are associated with epilepsy phenotypes ranging from mild FS to moderate generalized tonic-clonic seizures or more severe disorders such as Dravet syndrome (DS) or epileptic encephalopathies (further information found in <xref ref-type="bibr" rid="B82">Kang and Macdonald, 2016</xref>). In order to bridge the gap between known Œ≥2 trafficking mechanisms, identified protein interaction sites and human pathology, we examined Œ≥2 subunit genetic variation using the Genome Aggregation Database (gnomAD) (<xref ref-type="bibr" rid="B100">Lek et al., 2016</xref>), a dataset of exome sequence data from 123,136 individuals and whole genome sequencing from 15,496 unrelated individuals without any severe pediatric disease and their first-degree relatives. We focused specifically on synonymous (codon substitutions result in no amino acid sequence change) and non-synonymous (alter amino acid sequence) mutations. Although synonymous codon changes were previously labeled as ‚Äúsilent‚Äù mutations and thought to have limited consequences, recent data indicates these may also impact function and contribute to disease through effects on <italic>cis</italic>-regulatory elements, mRNA structure, and protein expression. Non-synonymous mutations that result in a stop codon are referred to as nonsense mutations whereas missense mutations result in the exchange of one amino acid for another. Non-synonymous mutations may affect structural and functional properties and be associated with a disease condition; however, others may be functionally neutral and not related to a disease phenotype. Protein domains which show significant diversity in mutations identify regions of genetic flexibility, while regions with low allele frequency events (standard threshold of 0.1%) identify potentially pathogenic mutations that are not evolutionarily favored (<xref ref-type="bibr" rid="B33">Dudley et al., 2012</xref>). In the Œ≥2S isoform, we identified and plotted the distribution of 104 synonymous and 122 non-synonymous missense variants (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>) (<xref ref-type="bibr" rid="B74">Jay and Brouwer, 2016</xref>). Five additional non-synonymous variants were found in the Œ≥2L specific sequence (LLRMFSFK: L377R, R379W, R379Q, F381L, S382C), while no synonymous variants were identified (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>). Of note, there is a third putative Œ≥2 isoform which appears conserved in humans and primates including the great apes and old world monkeys but absent in rodents that was not evaluated here for human genetic variation (ENST00000414552, Y211 is substituted by W, followed by 40 additional amino acids in the N-terminal extracellular domain). Overall, the latter half of the ECD, TM and linker regions showed low levels of missense variation when compared to synonymous variation (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Genetic variation of the Œ≥2 GABA<sub>A</sub>R subunit in gnomAD vs. genetic epilepsies. <bold>(A)</bold> The gnomAD dataset (individuals without any severe pediatric disease or their first-degree relatives) was used to identify a total of 104 control synonymous variants (gray) and 122 missense non-synonymous variants and plotted; each variant is represented by a lollipop marker that scales with allele frequency. Missense variants were categorized as neutral (blue) or deleterious (orange) through bioinformatics analysis using PROVEAN and SIFT predictions. Linear representation of the Œ≥2 GABA<sub>A</sub>R subunit with domains: signal peptide (SP; red); extracellular N-terminal region (ECD, blue), transmembrane domain including the four transmembrane helical regions (M1-M4, green); small loops between transmembrane regions (gray); and large intracellular domain between M3-M4 (ICD, purple). The residue numbers correspond to the Œ≥2S sequence (UniProt P18507). The independent ICD below shows the additional residues present in the Œ≥2L isoform (UniProt P18507-2), and 5 distinct missense variants identified, predicted as neutral by PROVEAN: L377R, R379W, R379Q, F381L, S382C. <bold>(B)</bold> Patient epilepsy disease related missense (red) and nonsense variants leading to early stop codons (dark purple) were compiled as described in Material and Methods and plotted on the linear protein structure. All genetic variant AA residue numbering includes signal peptide.</p>
</caption>
<graphic xlink:href="fncel-12-00265-g003"></graphic>
</fig>
<p>We next turned to the patient epilepsy disease case variants to determine if these are over-represented in similar regions. Disease case variants were gathered from National Center for Biotechnical Information (NCBI), ClinVar, and Human Gene Mutation Databases (HGMD), yielding a total of 49 pathogenic or likely pathogenic mutations including 25 missense, 11 nonsense, 9 frameshift, and 4 intron splice variants. The distribution of the 36 epilepsy-related missense and nonsense mutations was mapped across the Œ≥2 subunit protein domains (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). The 11 Œ≥2 nonsense variants resulted in early stop codons (X) throughout the following domains: (1) ECD = Q40X, L91X, R136X, Y180X, G273X; (2) M1 = Y274X (2 unique stop codon mutant variants), W295X; (3) ICD = Q390X, R425X, W429X. The 25 Œ≥2 subunit missense mutations showed wider distribution throughout the ECD, M1-4, M2-M3 linker and ICD regions. Comparison of the disease-associated and gnomAD missense variants identified significantly greater percentages of epilepsy related variants in the M2 and M2-M3 linker regions (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). In contrast, signal peptide missense mutations were not found and ICD missense mutations were less prevalent in epilepsy patients (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Genetic variation across <italic>GABRG2</italic> domains.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Region</th>
<th align="center" colspan="1" rowspan="1" valign="top">Residues</th>
<th align="center" colspan="1" rowspan="1" valign="top">GnomAD missense</th>
<th align="center" colspan="1" rowspan="1" valign="top">(<italic>n</italic> = 122)</th>
<th align="center" colspan="1" rowspan="1" valign="top">Disease-associated missense</th>
<th align="center" colspan="1" rowspan="1" valign="top">(<italic>n</italic> = 25)</th>
<th align="center" colspan="1" rowspan="1" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">#</td>
<td align="center" colspan="1" rowspan="1" valign="top">%</td>
<td align="center" colspan="1" rowspan="1" valign="top">#</td>
<td align="center" colspan="1" rowspan="1" valign="top">%</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Signal peptide</td>
<td align="center" colspan="1" rowspan="1" valign="top">1‚Äì39</td>
<td align="center" colspan="1" rowspan="1" valign="top">21</td>
<td align="center" colspan="1" rowspan="1" valign="top">17.21</td>
<td align="center" colspan="1" rowspan="1" valign="top">0</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>
<italic><sup>‚àó</sup>0.025</italic>
</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">40‚Äì273</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="center" colspan="1" rowspan="1" valign="top">43.44</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">48.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.8255</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M1</td>
<td align="center" colspan="1" rowspan="1" valign="top">274‚Äì296</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.46</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0616</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M1-M2 loop</td>
<td align="center" colspan="1" rowspan="1" valign="top">297‚Äì299</td>
<td align="center" colspan="1" rowspan="1" valign="top">0</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2</td>
<td align="center" colspan="1" rowspan="1" valign="top">300‚Äì325</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.64</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>
<italic><sup>‚àó</sup>0.0348</italic>
</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2-M3 loop</td>
<td align="center" colspan="1" rowspan="1" valign="top">326‚Äì333</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.64</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>
<italic><sup>‚àó</sup>0.0348</italic>
</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M3</td>
<td align="center" colspan="1" rowspan="1" valign="top">334‚Äì356</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.46</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.2006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="center" colspan="1" rowspan="1" valign="top">357‚Äì443</td>
<td align="center" colspan="1" rowspan="1" valign="top">33</td>
<td align="center" colspan="1" rowspan="1" valign="top">27.05</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>
<italic><sup>‚àó</sup>0.0096</italic>
</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M4</td>
<td align="center" colspan="1" rowspan="1" valign="top">444‚Äì466</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.10</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">C-Term</td>
<td align="center" colspan="1" rowspan="1" valign="top">467</td>
<td align="center" colspan="1" rowspan="1" valign="top">0</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Coordinates based on <italic>GABRG2</italic> (GenBank NM_000816.3 transcript variant 2 Œ≥2S, Uniprot P18507). ECD, extracellular amino-terminal domain; M1‚ÄìM4, transmembrane regions 1‚Äì4; ICD, intracellular domain; C-Term, carboxy-terminus. Fisher‚Äôs exact <italic>t-</italic>test <italic>p</italic>-values are reported; <sup>‚àó</sup>denotes statistical significance.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>In the field of medical genomics, identification of potentially pathological mutations is a significant challenge, prompting the development of multiple bioinformatics methods to assess non-synonymous variants. We used the sequence homology-based genetic analysis bioinformatics programs PROVEAN (Protein Variation Effect Analyzer) and SIFT (Sorting Intolerant from Tolerant) to assess non-synonymous variants in the gnomAD population and predict the effects on Œ≥2 subunit biological function. Interestingly, 35 of the 122 non-synonymous gnomAD variants were also predicted to be putatively damaging/deleterious by both of the two bioinformatics tools (scoring agreement at 81.9%, <bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>, orange colored variants). Neutral scored non-synonymous variants included S386P and T388A (aka S355 and T357 phosphorylation sites, <bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>). None of the Œ≥2L isoform missense variants were predicted by PROVEAN as damaging, although S382C (aka S343, the PKC/CaMKII phosphorylation site, see earlier Synaptic Accumulation and Functional Regulation, <bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>) was predicted as possibly damaging by SIFT. Among the gnomAD population six variants were identified that overlapped the epilepsy patient missense group (L57F, N79S, M199V, R177Q, A334T, R363Q): three were predicted as deleterious (N79S, M199V, A334T) and 3 as neutral (L57F, R177Q, R363Q). PROVEAN and SIFT bioinformatics analysis of the 25 epilepsy patient missense variants showed four as neutral (L57F, A106T, L307V and R363Q), two had conflicting predictions (L74V, R304K), and all others were scored as damaging. As the gnomAD population is relatively free from significant clinical disorders, this implies masking by epistatic genetic interactions, consistent with phenotypic variability seen in epilepsy patients and animal epilepsy models. In addition, although <italic>in silico</italic> prediction tools show overall robust performance, particularly when software are used in combination (<xref ref-type="bibr" rid="B101">Leong et al., 2015</xref>; <xref ref-type="bibr" rid="B116">Masica and Karchin, 2016</xref>), this suggests pathological variants can be missed. Improving clinically admissible predictions from these <italic>in silico</italic> tools is a current high priority focus in medical bioinformatics (<xref ref-type="bibr" rid="B116">Masica and Karchin, 2016</xref>; <xref ref-type="bibr" rid="B35">Ernst et al., 2018</xref>). To expand our insight into the cellular pathology underlying the thirty-six patient cases, we next cross-examined database information (NCBI, ClinVar, HGMD) and the current literature for disease phenotypic and cellular study based analysis.</p>
</sec>
<sec>
<title>Patient Epilepsy Phenotypes</title>
<p>The most common patient phenotypes associated with nonsense and missense mutations ranged in severity and included FS, generalized tonic-clonic seizures (GTCS), GTCS with FS, genetic epilepsy with FS (GEFS), genetic epilepsy (GE), DS, and epileptic encephalopathy with severe global developmental delays (EEDD). FS are a relatively mild pathology which occur in the presence of fevers and display tonic-clonic seizure activity in individuals between 6 months and 5 years of age (<xref ref-type="bibr" rid="B11">Boillot et al., 2015</xref>). FS which have prolonged episode duration and occur past 6 years of age are termed FS+ and are generally associated with increased risk for developing epilepsy later in life. Moderate forms of epilepsy include GTCS and GE both with and without FS, where FS can co-occur with persistent seizure episodes past childhood and can present intense seizure activity more commonly known as a ‚Äúgrand mal‚Äù seizure as in the case of GTCS (<xref ref-type="bibr" rid="B76">Johnston et al., 2014</xref>; <xref ref-type="bibr" rid="B188">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B40">Fisher et al., 2017</xref>). The most severe phenotypes reported are DS and EEDD. In particular, DS is subset of epileptic encephalopathy and is characterized by a wide range of seizure type activity as well as psychomotor development delays, ataxia and hyperkinesis emerging between the ages of 1‚Äì4 (<xref ref-type="bibr" rid="B71">Ishii et al., 2014</xref>; <xref ref-type="bibr" rid="B40">Fisher et al., 2017</xref>). In contrast, EEDD have broader phenotypic manifestations and deficits as a result of global neurodevelopmental impairments with treatment-resistant seizures (<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>). Less common reported patient phenotypes included myoclonic epilepsy, absence seizures, complex partial seizures, tonic infantile spasms, tonic seizures, Rolandic epilepsy, and ASD with learning difficulties. <italic>In vitro</italic> studies have been invaluable in gaining in depth understanding of etiology, cellular pathology, and functional effects of these epilepsy patient variants.</p>
</sec>
<sec>
<title>Œ≥2 Subunit Disease Case Analysis</title>
<p><italic>In vitro</italic> studies on 17 of the Œ≥2 pathogenic variants have revealed reduced surface expression in 15 cases, in part resulting from ER retention and trafficking defects (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). The severe disease DS epilepsy phenotype is associated with three nonsense mutations (Q40X, R136X, Q390X) and one missense (P302L) mutation (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). The early occurrence of Q40X and R136X within the ECD resulted in premature termination codons (PTCs) and mRNA degradation via nonsense mediated mRNA decay (NMD) with decreased Œ≥2 protein levels. The introduction of upstream PTCs limited the availability of trafficable Œ≥2, diminished overall receptor surface expression and synaptic localization and resulted in significant GABAergic deficits (<xref ref-type="bibr" rid="B71">Ishii et al., 2014</xref>). Conversely, the Q390X (previously known as Q351X) mutation occurs in the ICD and escapes NMD but is instead subject to ubiquitin-proteasome degradation (<xref ref-type="bibr" rid="B85">Kang et al., 2013</xref>). <italic>In vitro</italic> experiments found Q390X to have comparable mRNA levels to other late sequence nonsense mutations but dissimilar protein expression due to different degradation rates. Q390X displayed a substantially longer half-life as compared to wild-type Œ≥2 and other nonsense mutant subunits in addition to an increased ability to oligomerize with and sequester wild-type Œ± and Œ≤ subunits. This alternative disruption in receptor trafficking provides evidence that expressed non-functional truncated subunits may be modifiers of epilepsy phenotype severity. Interestingly, P302L was the only missense mutation reported in a patient with DS (<xref ref-type="bibr" rid="B62">Hernandez et al., 2017</xref>). Of note, this mutation resides in M2 and contributes to the formation of the ion channel pore which likely explains its severe phenotype. This is supported by P302L mutant electrophysiological studies and structural modeling which suggests a shift in pore activity resulting in slow activation, low conductance states, and fast desensitization of GABA<sub>A</sub>R (<xref ref-type="bibr" rid="B62">Hernandez et al., 2017</xref>). In contrast, all six cases of EEDD were found in patients with missense mutations (A106T, I107T, P282S, R323W, R323Q, F343L) dispersed throughout structural domains (ECD, M1 and M2) and exhibited additional epileptic phenotypes such as GTCS, GEFS, and tonic seizures (<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>). In fact, the I107T mutation is located in the ECD which typically tolerates missense mutations as evidenced by relatively mild phenotypes; however, this mutation was found to exhibit the most severe cellular pathologies as compared to other disease variants emphasizing the need to further investigate these mutations and their ramifications on cellular processes.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p><italic>GABRG2</italic> missense and nonsense patient mutations with associated cellular pathologies and reported clinical phenotypes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="center" colspan="5" rowspan="1" valign="top">Cellular Pathalogy<hr/></th>
<th align="center" colspan="6" rowspan="1" valign="top">Phenotype<hr/></th>
<th align="left" colspan="1" rowspan="1" valign="top">Publication(s)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Region</th>
<th align="center" colspan="1" rowspan="1" valign="top">Variant</th>
<th align="center" colspan="1" rowspan="1" valign="top">Trafficking</th>
<th align="center" colspan="1" rowspan="1" valign="top">ER retention</th>
<th align="center" colspan="1" rowspan="1" valign="top">Surface expression</th>
<th align="center" colspan="1" rowspan="1" valign="top">Cell current</th>
<th align="center" colspan="1" rowspan="1" valign="top">Febrile seizures</th>
<th align="center" colspan="1" rowspan="1" valign="top">Generalized tonic-clonic seizures</th>
<th align="center" colspan="1" rowspan="1" valign="top">Genetic epilepsy</th>
<th align="center" colspan="1" rowspan="1" valign="top">Dravet syndrome</th>
<th align="center" colspan="1" rowspan="1" valign="top">Epileptic encephalopathy</th>
<th align="center" colspan="1" rowspan="1" valign="top">Other</th>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">Q40X</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B65">Hirose et al., 2005</xref>; <xref ref-type="bibr" rid="B69">Huang et al., 2012</xref>; <xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Ishii et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">L57F</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Äì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Äì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B61">Hernandez et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">N79S</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Äì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B158">Shi et al., 2010</xref>; <xref ref-type="bibr" rid="B120">Migita et al., 2013</xref>; <xref ref-type="bibr" rid="B68">Huang et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">R82Q</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B186">Wallace et al., 2001</xref>; <xref ref-type="bibr" rid="B8">Bianchi et al., 2002</xref>; <xref ref-type="bibr" rid="B13">Bowser et al., 2002</xref>; <xref ref-type="bibr" rid="B111">Macdonald et al., 2003</xref>; <xref ref-type="bibr" rid="B81">Kang and Macdonald, 2004</xref>; <xref ref-type="bibr" rid="B152">Sancar and Czajkowski, 2004</xref>; <xref ref-type="bibr" rid="B83">Kang et al., 2006</xref>; <xref ref-type="bibr" rid="B36">Eugene et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Frugier et al., 2007</xref>; <xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>; <xref ref-type="bibr" rid="B23">Chaumont et al., 2013</xref>; <xref ref-type="bibr" rid="B7">Bennett et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">P83S</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B97">Lachance-Touchette et al., 2011</xref>; <xref ref-type="bibr" rid="B68">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="B7">Bennett et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">A106T</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">I107T</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">R136X</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B85">Kang et al., 2013</xref>; <xref ref-type="bibr" rid="B76">Johnston et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="center" colspan="1" rowspan="1" valign="top">G257R</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Äì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B147">Reinthaler et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M1</td>
<td align="center" colspan="1" rowspan="1" valign="top">P282S</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2</td>
<td align="center" colspan="1" rowspan="1" valign="top">P302L</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Äì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üî</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B62">Hernandez et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2</td>
<td align="center" colspan="1" rowspan="1" valign="top">R323W</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2</td>
<td align="center" colspan="1" rowspan="1" valign="top">R323Q</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B21">Carvill et al., 2013</xref>; <xref ref-type="bibr" rid="B147">Reinthaler et al., 2015</xref>; <xref ref-type="bibr" rid="B155">Shen et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M2-M3 loop</td>
<td align="center" colspan="1" rowspan="1" valign="top">K328M</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B6">Baulac et al., 2001</xref>; <xref ref-type="bibr" rid="B8">Bianchi et al., 2002</xref>; <xref ref-type="bibr" rid="B111">Macdonald et al., 2003</xref>, <xref ref-type="bibr" rid="B112">2012</xref>; <xref ref-type="bibr" rid="B146">Ramakrishnan and Hess, 2004</xref>; <xref ref-type="bibr" rid="B65">Hirose et al., 2005</xref>; <xref ref-type="bibr" rid="B83">Kang et al., 2006</xref>; <xref ref-type="bibr" rid="B36">Eugene et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Frugier et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Bouthour et al., 2012</xref>; <xref ref-type="bibr" rid="B7">Bennett et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M3</td>
<td align="center" colspan="1" rowspan="1" valign="top">F343L</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="center" colspan="1" rowspan="1" valign="top">Q390X</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B162">Singh et al., 1999</xref>; <xref ref-type="bibr" rid="B57">Harkin et al., 2002</xref>; <xref ref-type="bibr" rid="B83">Kang et al., 2006</xref>, <xref ref-type="bibr" rid="B84">2009</xref>; <xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>; <xref ref-type="bibr" rid="B85">Kang et al., 2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="center" colspan="1" rowspan="1" valign="top">W429X</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üë</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚Üì‚Üì</td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">‚úì</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B168">Sun et al., 2008</xref>; <xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>; <xref ref-type="bibr" rid="B85">Kang et al., 2013</xref>; <xref ref-type="bibr" rid="B188">Wang et al., 2016</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Variants are organized by nucleotide sequence position, and variants ending in ‚ÄòX‚Äô are nonsense mutations with all others being missense mutations. Other epileptic or developmental phenotypes include absence seizures, complex partial seizures, severe global developmental delay, tonic infantile spasms, autism disorder with learning difficulties, Rolandic epilepsy, or epilepsy with myoclonic-astatic seizures; ECD, extracellular amino-terminal domain; M1‚ÄìM3, transmembrane regions 1‚Äì3; ICD, intracellular domain; ‚Üì‚Üì, reduced; ‚Üë, increased; ‚úì, observed; ‚úì, unknown; -, not affected/changed; ‚Üì, slightly reduced; ‚Üî, possibly.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>The moderate epileptic phenotype GEFS without co-occurring conditions was observed in three cases with two missense (P83S and K328M) and one nonsense (W429X) variants reported with structural locations in the ECD, M2-M3 linker, and ICD, respectively (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). P83S was found to reduce GABA-evoked whole cell currents mainly through a plasma membrane and trafficking-dependent manner (<xref ref-type="bibr" rid="B97">Lachance-Touchette et al., 2011</xref>; <xref ref-type="bibr" rid="B68">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="B7">Bennett et al., 2017</xref>). In contrast, K328M (previously known as K289M) is found in the short extracellular loop between the M2-M3 regions and was found to increase receptor deactivation, implicating this region in receptor kinetic properties (<xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>). Conversely, W429X displayed less drastic protein degradation and subunit oligomerization pathologies compared to the previously discussed DS variant Q390X (<xref ref-type="bibr" rid="B188">Wang et al., 2016</xref>). The later downstream incidence of W429X combined with slightly higher surface expression compared to Q390X may explain the milder epilepsy phenotype (<xref ref-type="bibr" rid="B168">Sun et al., 2008</xref>; <xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>; <xref ref-type="bibr" rid="B85">Kang et al., 2013</xref>; <xref ref-type="bibr" rid="B188">Wang et al., 2016</xref>).</p>
<p>Throughout the reviewed mutations, only two variants (L57F and N79S) deviated from a pathology associated with reduced Œ≥2 containing GABA<sub>A</sub>R plasma membrane levels and were located in the ECD. L57F was present in an individual with GE and found to have normal surface and trafficking characteristics compared to wild-type Œ≥2 receptors; however, altered current density properties and function were observed possibly due to minor structural perturbations in the Œ±1-helix of the ECD (<xref ref-type="bibr" rid="B61">Hernandez et al., 2016</xref>). Comparatively, the N79S mutation was the sole occurrence of GTCS without co-occurring phenotypes and presented slight but significant impairments in plasma membrane levels and peak current amplitude (<xref ref-type="bibr" rid="B68">Huang et al., 2014</xref>) suggesting it is more of a susceptibility variant as opposed to an epilepsy mutation (<xref ref-type="bibr" rid="B158">Shi et al., 2010</xref>; <xref ref-type="bibr" rid="B120">Migita et al., 2013</xref>; <xref ref-type="bibr" rid="B68">Huang et al., 2014</xref>). Moreover, the resilience of the ECD is further supported by R82Q (previously known as R43Q), a well characterized missense mutation associated with mild phenotypic manifestations like FS and absence seizures with trafficking deficient pathologies (<xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>). Overall, the 13 frameshift and intron splice variant mutations analyzed were associated with mild phenotypes, though further studies are needed to elucidate their pathological mechanisms (<bold>Table <xref ref-type="table" rid="T3">3</xref></bold>). However, frameshift mutations within the ICD (E402Dfs<sup>‚àó</sup>3 generating a stop codon at Y404X critical Src/Fyn phospho site discussed earlier; and S443delC resulting in an altered and elongated carboxy terminus with +50 novel AA) were associated with more moderate-severe phenotypes like GTCS and GEFS+ underscoring the importance for intracellular regulation via the ICD (<xref ref-type="bibr" rid="B112">Macdonald et al., 2012</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Patient frameshift mutations and intron splice variants associated or likely associated with various epilepsy phenotypes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Region</th>
<th align="left" colspan="1" rowspan="1" valign="top">Canonical sequence codon</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutant sequence</th>
<th align="left" colspan="1" rowspan="1" valign="top">Variant name</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation type</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotype(s)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function effect(s)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="left" colspan="1" rowspan="1" valign="top">ACT-CCA-AAA 58 59 60</td>
<td align="left" colspan="1" rowspan="1" valign="top">ACA-CAA-AAG</td>
<td align="left" colspan="1" rowspan="1" valign="top">P59Qfs<sup>‚àó</sup>12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Febrile Seizures, Tonic-Clonic Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to undergo NMD (<xref ref-type="bibr" rid="B11">Boillot et al., 2015</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="left" colspan="1" rowspan="1" valign="top">TTT-GCG-CAA 117 118 119</td>
<td align="left" colspan="1" rowspan="1" valign="top">TTT-TGC-GCA</td>
<td align="left" colspan="1" rowspan="1" valign="top">A118Cfs<sup>‚àó</sup>6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to undergo NMD (<xref ref-type="bibr" rid="B31">Della Mina et al., 2015</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAA-GCT-GAT 57 58 59</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAG-CTG-ATG</td>
<td align="left" colspan="1" rowspan="1" valign="top">A158Lfs<sup>‚àó</sup>13</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to cause loss of normal protein function either through protein truncation or NMD. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="left" colspan="1" rowspan="1" valign="top">CGA-GTG-CTC 177 178 179</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAG-TGC-TCT</td>
<td align="left" colspan="1" rowspan="1" valign="top">R177Qfs<sup>‚àó</sup>6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood Absence Epilepsy, Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to cause loss of normal protein function either through protein truncation or NMD. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">CTT-AGG-TTG Int4 Int4 184</td>
<td align="left" colspan="1" rowspan="1" valign="top">CTG-AGG-TTG</td>
<td align="left" colspan="1" rowspan="1" valign="top">549-3T &gt; G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron Splice Variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal gene splicing; <italic>in silico</italic> assessment predicts altered protein function (<xref ref-type="bibr" rid="B147">Reinthaler et al., 2015</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">TCC-GTG-AAG 256 Int6 Int6</td>
<td align="left" colspan="1" rowspan="1" valign="top">TCC-GGG-AAG</td>
<td align="left" colspan="1" rowspan="1" valign="top">IVS6 + 2T‚Äì &gt; G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron Splice Variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood Absence Epilepsy, Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Truncation; ER retention; undergo NMD; decreased surface Œ≥2 subunit levels and GABA-evoked whole cell currents; and increased ER stress marker BIP (<xref ref-type="bibr" rid="B79">Kananura et al., 2002</xref>; <xref ref-type="bibr" rid="B173">Tian and Macdonald, 2012</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ECD</td>
<td align="left" colspan="1" rowspan="1" valign="top">GGA-GAT-TAT 257 258 259</td>
<td align="left" colspan="1" rowspan="1" valign="top">AGA-GAT-TAT</td>
<td align="left" colspan="1" rowspan="1" valign="top">770-1G &gt; A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron Splice Variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Suspected to cause epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to cause abnormal gene splicing and undergo NMD or the production of an abnormal protein. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M3</td>
<td align="left" colspan="1" rowspan="1" valign="top">GTT-TGT-TTC 341 342 343</td>
<td align="left" colspan="1" rowspan="1" valign="top">GTT-TTT-TCA</td>
<td align="left" colspan="1" rowspan="1" valign="top">C342Ffs<sup>‚àó</sup>50</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood Absence Epilepsy, Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not anticipated to result in NMD but expected to result in a truncated protein. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FproveIntron 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAG-GCC-CCT Int8 377 378</td>
<td align="left" colspan="1" rowspan="1" valign="top">CGG-GCC-CCT</td>
<td align="left" colspan="1" rowspan="1" valign="top">1129-2A &gt; G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron Splice Variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood Absence Epilepsy, Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not anticipated to undergo NMD, but likely alters RNA splicing and disrupts protein function. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATT-CAA-GAG 397 398 399</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATT-CGA-GAG</td>
<td align="left" colspan="1" rowspan="1" valign="top">Q398Rfs<sup>‚àó</sup>4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to cause protein truncation. #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="left" colspan="1" rowspan="1" valign="top">GAA-GAG-TAC 402 403 404</td>
<td align="left" colspan="1" rowspan="1" valign="top">GAT-TCA-TGA</td>
<td align="left" colspan="1" rowspan="1" valign="top">E402Dfs<sup>‚àó</sup>3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Febrile Seizures, Temporal Lobe Encephalopathy, Generalized Tonic-Clonic Seizures, Focal seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to cause protein truncation (<xref ref-type="bibr" rid="B11">Boillot et al., 2015</xref>). #</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICD</td>
<td align="left" colspan="1" rowspan="1" valign="top">TCC-TAT-GCT 443 444 445</td>
<td align="left" colspan="1" rowspan="1" valign="top">TCT-ATG-TCT</td>
<td align="left" colspan="1" rowspan="1" valign="top">S443delC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Genetic Epilepsy with Febrile Seizures Plus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Produced elongated peptide with 50 novel amino acids compared to Œ≥2S; trafficking impairments, ER retention, decreased surface expression and whole cell currents (<xref ref-type="bibr" rid="B174">Tian et al., 2013</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M4</td>
<td align="left" colspan="1" rowspan="1" valign="top">GTC-TCC-TAC 462 463 464</td>
<td align="left" colspan="1" rowspan="1" valign="top">TCT-CCT-ACC</td>
<td align="left" colspan="1" rowspan="1" valign="top">V462Sfs<sup>‚àó</sup>33</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frame shift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Febrile Seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predicted to escape NMD and produce elongated peptide with 32 novel amino acids as compared to Œ≥2S (<xref ref-type="bibr" rid="B11">Boillot et al., 2015</xref>). #</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Patient variants are ordered by nucleotide sequence position of <italic>GABRG2</italic>. Nucleotides deleted (red) and inserted (green) for each variant are noted. ECD, extracellular amino-terminal domain; M3-M4, transmembrane regions 3-4; ICD, intracellular domain; NMD, nonsense-mediated mRNA decay; introduction of downstream premature stop codon following specified number of codons (<sup>‚àó</sup>); predicted function from GeneDX (#).</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>In summary, both deficits in GABA<sub>A</sub>R surface trafficking and the functional role of specific Œ≥2 subunit regions are critical factors modulating phenotypic outcome, with some missense mutations resulting in phenotypes as severe as nonsense mutations. Furthermore, expressed non-functional truncated subunits may be correlated with more severe manifestations and be modifiers of disease phenotypes. Disease case variants in the pore lining M2 region showed particularly severe phenotypes, consistent with the reduced genetic variation in this region in gnomAD non-synonymous variants. Clearly, <italic>in vitro</italic> studies of recombinant receptor trafficking, electrophysiology and assembly have provided important insight into the underlying cellular pathology and functional effects of these epilepsy patient variants. Greater understanding of the consequences of Œ≥2 genetic variation, both for revealing disease mechanisms and for GABA<sub>A</sub>R synaptic plasticity will be gained through application of innovative imaging methods in the neuronal context.</p>
</sec>
</sec>
<sec>
<title>Looking Forward: Imaging Advances</title>
<p>Advancing imaging techniques are providing critical insight into GABA<sub>A</sub>R trafficking extending beyond basic endo/exocytic trafficking of receptors. Live-cell imaging using pH-sensitive GFP (pHluorin) tagged GABA<sub>A</sub>Rs subunits and fluorescence recovery after photobleaching (FRAP) experiments first identified GABA<sub>A</sub>R synaptic retention, limiting diffusion at synaptic release sites, and the crucial role of gephyrin in this process (<xref ref-type="bibr" rid="B72">Jacob et al., 2005</xref>). Receptor subunits with pHluorin tags have further described GABA<sub>A</sub>R surface levels and lysosomal degradation (<xref ref-type="bibr" rid="B73">Jacob et al., 2012</xref>; <xref ref-type="bibr" rid="B109">Lorenz-Guertin et al., 2017</xref>) and novel exocytic machinery and insertion sites of receptors (<xref ref-type="bibr" rid="B54">Gu et al., 2016</xref>). The pHluorin-FRAP technique is often performed in addition to the newer workhorse of diffusion studies, quantum dot (QD) single-particle tracking. QD studies have revealed precise quantitative properties of synaptic and extrasynaptic GABA<sub>A</sub>R diffusion during baseline conditions (<xref ref-type="bibr" rid="B149">Renner et al., 2012</xref>), excitatory stimulation (including iLTP) (<xref ref-type="bibr" rid="B3">Bannai et al., 2009</xref>, <xref ref-type="bibr" rid="B4">2015</xref>; <xref ref-type="bibr" rid="B126">Muir et al., 2010</xref>; <xref ref-type="bibr" rid="B134">Niwa et al., 2012</xref>; <xref ref-type="bibr" rid="B127">Muir and Kittler, 2014</xref>; <xref ref-type="bibr" rid="B140">Petrini et al., 2014</xref>), GABA<sub>A</sub>R agonist and/or drug treatment (<xref ref-type="bibr" rid="B50">Gouzer et al., 2014</xref>; <xref ref-type="bibr" rid="B104">Levi et al., 2015</xref>; <xref ref-type="bibr" rid="B30">de Luca et al., 2017</xref>), GABA<sub>B</sub> receptor activation (<xref ref-type="bibr" rid="B44">Gerrow and Triller, 2014</xref>), purinergic (P2x2 receptor) activation (<xref ref-type="bibr" rid="B159">Shrivastava et al., 2011</xref>), and changes in gephyrin or radixin phosphorylation (<xref ref-type="bibr" rid="B59">Hausrat et al., 2015</xref>; <xref ref-type="bibr" rid="B5">Battaglia et al., 2018</xref>). Receptor functional regulation by changes in surface diffusion, perhaps completely independent of changes in surface levels, represents a paradigm shift in our basic understanding of synaptic plasticity. Indeed current studies of human genetic variants in recombinant systems are unlikely to detect these fundamentally important properties due to lack of a neuronal context, the appropriate GABA<sub>A</sub>R subunit complement, interacting proteins, and general overexpression problems. For example, QD neuronal studies of the Œ≥2 K328M disease variant revealed an additional phenotype of enhanced temperature sensitive receptor diffusion, likely contributing to the FS pathology in patients (<xref ref-type="bibr" rid="B12">Bouthour et al., 2012</xref>).</p>
<p>To address multiple trafficking questions within a single assay, our group recently engineered a GABA<sub>A</sub>R Œ≥2 subunit dual fluorescent sensor encoding a pHluorin tag and a fluorogen-activating peptide (FAP) (Œ≥2<sup>pH</sup>FAP) (<xref ref-type="bibr" rid="B109">Lorenz-Guertin et al., 2017</xref>). FAPs are antibody single chain variable fragments characterized to selectively bind inorganic dyes with high specificity and affinity (<xref ref-type="bibr" rid="B169">Szent-Gyorgyi et al., 2008</xref>). The dyes are non-fluorescent until bound by a FAP and individual dyes have unique characteristics including cell permeability, pH-sensitivity, fluorescent properties, and <italic>in vivo</italic> administration capability (<xref ref-type="bibr" rid="B39">Fisher et al., 2010</xref>; <xref ref-type="bibr" rid="B53">Grover et al., 2012</xref>; <xref ref-type="bibr" rid="B153">Saunders et al., 2012</xref>; <xref ref-type="bibr" rid="B198">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="B60">He et al., 2016</xref>). We have used the FAP-dye system in neurons to selectively examine cell surface GABA<sub>A</sub>Rs undergoing internalization, early endosomal accumulation and targeting to late endosomes/lysosomes via confocal live-imaging (<xref ref-type="bibr" rid="B109">Lorenz-Guertin et al., 2017</xref>). Pulse-labeling Œ≥2<sup>pH</sup>FAP with cell impermeable dye allows for detection of surface receptor turnover rates independent of a change in total GABA<sub>A</sub>R surface levels, as we demonstrated using a mild seizure protocol. As more GABA<sub>A</sub>Rs subunits are engineered to express the FAP tag, and additional unique dyes are synthesized to address specific experimental questions, the utility of this imaging approach continues to grow.</p>
<p>Other innovative imaging approaches advancing our ability to detect changes in GABA<sub>A</sub>R synaptic plasticity include optogenetic toolkits for controlling GABA<sub>A</sub>R activity (<xref ref-type="bibr" rid="B105">Lin et al., 2014</xref>, <xref ref-type="bibr" rid="B106">2015</xref>), spatially regulated GABA activation using two-photon photolysis (<xref ref-type="bibr" rid="B135">Oh et al., 2016</xref>), proximity ligation assays to measure endogenous protein interaction (<xref ref-type="bibr" rid="B163">Smith et al., 2014</xref>; <xref ref-type="bibr" rid="B179">Tseng et al., 2015</xref>; <xref ref-type="bibr" rid="B45">Ghosh et al., 2016</xref>), and super-resolution imaging and other fluorescent tools to examine inhibitory gephyrin scaffolding (<xref ref-type="bibr" rid="B51">Gross et al., 2013</xref>, <xref ref-type="bibr" rid="B52">2016</xref>; <xref ref-type="bibr" rid="B160">Sigal et al., 2015</xref>; <xref ref-type="bibr" rid="B113">Maric et al., 2017</xref>; <xref ref-type="bibr" rid="B138">Pennacchietti et al., 2017</xref>). Fluorescence resonance energy transfer (FRET) techniques have been limitedly applied to studying GABA<sub>A</sub>R trafficking or receptor subunit composition (<xref ref-type="bibr" rid="B32">Ding et al., 2010</xref>; <xref ref-type="bibr" rid="B159">Shrivastava et al., 2011</xref>), collectively suggesting imaging techniques will be a rich resource of novel GABA<sub>A</sub>R knowledge.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In summary, we live in an unprecedented time for understanding human disease pathology and neurodevelopment through integration of ‚Äúbig data‚Äù on human genetic variation and protein interaction networks/interactomes, in combination with high resolution live-imaging approaches. Future efforts to resolve GABA<sub>A</sub>R pathologies will benefit from connecting genetic variants to their cellular mechanisms of pathology within the complexity of neuronal signaling. Importantly, increased understanding of surface and intracellular pool regulated trafficking of GABA<sub>A</sub>R will provide mechanisms to treat overall reduced receptor levels in various disease states. Future treatment of genetic epilepsy syndromes are likely to involve CRISPR-Cas9 gene editing (<xref ref-type="bibr" rid="B110">Ma et al., 2017</xref>), RNA focused REPAIR editing approaches, or application of improved drugs that act as chaperones to promote receptor trafficking. The new imaging based methods described here are particularly likely to show high utility in both identifying cellular pathology of human GABA<sub>A</sub>R genetic variants and for drug screening efforts in a neuronal context.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Data Mining of <italic>GABRG2</italic> Genetic Variation</title>
<p>The prevalence of Œ≥2 subunit non-synonymous and synonymous variations in gnomAD<sup><xref ref-type="fn" rid="fn01">1</xref></sup>, currently a dataset of exome sequence data from 123,136 individuals and whole genome sequencing from 15,496 unrelated individuals, was assessed and restricted to those meeting the ‚ÄúPASS‚Äù quality threshold (<xref ref-type="bibr" rid="B100">Lek et al., 2016</xref>). Individuals known to be affected by severe pediatric disease are not contained in this data set, or their first-degree relatives. Next ‚Äúpathogenic‚Äù and ‚Äúlikely pathogenic‚Äù patient case variants not present in the gnomAD dataset were investigated in National Center for Biotechnical Information variation viewer (NCBIvv)<sup>1</sup>, ClinVar, and Human Gene Mutation Databases (HGMD) utilizing the following search parameters: GRCh37.p13 annotation release 105 assembly and NM_000816.3 (transcript variant 2, Œ≥2S). The search in NCBIvv identified 17 variants (accessed January 2018). The ClinVar search (accessed February 2018) confirmed 16/17 candidate variants with the outlier (R323W) having been newly identified in the literature (<xref ref-type="bibr" rid="B155">Shen et al., 2017</xref>)<sup><xref ref-type="fn" rid="fn02">2</xref></sup>. In addition to those confirmed, the ClinVar investigation produced 10 additional mutations. Some variants identified in ClinVar had associated predicted functions (submitted by GeneDX genetics company)<sup><xref ref-type="fn" rid="fn03">3</xref></sup>. Finally, HGMD (hgmd2018.1; accessed March 2018) interrogation uncovered 22 disease-causing mutations that were absent from NCBIvv and ClinVar inquiries<sup><xref ref-type="fn" rid="fn04">4</xref></sup>. Using these candidate case variants and their associated database information, the current literature was evaluated for disease phenotypic and cellular study based implications yielding a total of 49 pathogenic or likely pathogenic mutations including 25 missense, 11 nonsense, 9 frameshift, and 4 intron splice variants. We used lollipops-v.1.3.1 software (<xref ref-type="bibr" rid="B74">Jay and Brouwer, 2016</xref>) to plot the distribution of synonymous, non-synonymous and disease case mutations in <italic>GABRG2</italic> along a linear Œ≥2S assembly (P18507, ENST00000361925) and a linear segment representation of the additional eight encoded amino acids within the ICD in the Œ≥2L isoform (P18507-2, ENST00000356592). The missense and nonsense disease case variants studied at the cellular trafficking level were included in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>. The frameshift and intron splice variants were annotated in <bold>Table <xref ref-type="table" rid="T3">3</xref></bold>.</p>
</sec>
<sec>
<title>Bioinformatics Tools</title>
<p>PROVEAN (Protein Variation Effect Analyzer<sup><xref ref-type="fn" rid="fn05">5</xref></sup> (<xref ref-type="bibr" rid="B24">Choi et al., 2012</xref>) and SIFT (Sorting Intolerant from Tolerant) algorithms (<xref ref-type="bibr" rid="B67">Hu and Ng, 2013</xref>) are bioinformatics tools which predict whether an amino acid substitution or indel (insertion or deletion) has an impact on a protein‚Äôs biological function using homology based genetic analysis. Currently PROVEAN provides scoring via both PROVEAN and SIFT algorithms. PROVEAN utilizes pairwise sequence alignment scores to generate pre-computed predictions at every amino acid position in all human and mouse protein sequences. Mutations are predicted to be deleterious or tolerant based on the prediction cutoff value of -2.5: scores smaller than -2.5 are considered deleterious. Similarly, SIFT predicts whether the amino acid substitution alter the protein function based on sequence homology and the physical properties of amino acids. The intolerant range of SIFT is ‚â§0.05 for predicted damaging/deleterious mutations and a score of &gt;0.05 predicts the tolerant range.</p>
</sec>
</sec>
<sec>
<title>Web Resources</title>
<list list-type="simple" prefix-word="simple">
<list-item>
<label>‚Ä¢</label>
<p>gnomAD, <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link></p>
</list-item>
<list-item>
<label>‚Ä¢</label>
<p>ClinVar, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link></p>
</list-item>
<list-item>
<label>‚Ä¢</label>
<p>Human Gene Mutation Database, <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.org/">http://www.hgmd.org/</ext-link></p>
</list-item>
<list-item>
<label>‚Ä¢</label>
<p>Lollipops v.1.3.1, <ext-link ext-link-type="uri" xlink:href="https://github.com/pbnjay/lollipops/releases">https://github.com/pbnjay/lollipops/releases</ext-link></p>
</list-item>
<list-item>
<label>‚Ä¢</label>
<p>UniProt, <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link></p>
</list-item>
</list>
</sec>
<sec>
<title>Author Contributions</title>
<p>JL-G and TJ wrote and edited the sections ‚ÄúŒ≥2 Subunit Trafficking and Interactors‚Äù and ‚ÄúLooking Forward: Imaging Advances.‚Äù MB and TJ analyzed, wrote, and prepared the section ‚ÄúHuman Genetic Variation of Œ≥2 and Pathological Implications‚Äù and associated tables. TJ prepared all the figures. MB prepared all the tables.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MG and handling Editor declared their shared affiliation at the time of review.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was generously funded by T32GM008424 and R56MH114908-01, the William C. deGroat Neuropharmacology Departmental Fellowship, and Pharmacology and Chemical Biology Startup Funds.</p>
</fn>
</fn-group>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/transcript/ENST00000361925">http://gnomad.broadinstitute.org/transcript/ENST00000361925</ext-link>
</p>
</fn>
<fn id="fn02">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar">https://www.ncbi.nlm.nih.gov/clinvar</ext-link>
</p>
</fn>
<fn id="fn03">
<label>3</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.genedx.com/">https://www.genedx.com/</ext-link>
</p>
</fn>
<fn id="fn04">
<label>4</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GABRG2">http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GABRG2</ext-link>
</p>
</fn>
<fn id="fn05">
<label>5</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org">http://provean.jcvi.org</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alldred</surname><given-names>M. J.</given-names></name><name><surname>Mulder-Rosi</surname><given-names>J.</given-names></name><name><surname>Lingenfelter</surname><given-names>S. E.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>594</fpage>‚Äì<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4011-04.2005</pub-id>
<pub-id pub-id-type="pmid">15659595</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Yuen</surname><given-names>E. Y.</given-names></name><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Saliba</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Ubiquitin-dependent lysosomal targeting of GABA(A) receptors regulates neuronal inhibition.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>17552</fpage>‚Äì<lpage>17557</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0905502106</pub-id>
<pub-id pub-id-type="pmid">19815531</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Levi</surname><given-names>S.</given-names></name><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Launey</surname><given-names>T.</given-names></name><name><surname>Racine</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Activity-dependent tuning of inhibitory neurotransmission based on GABAAR diffusion dynamics.</article-title>
<source/><italic>Neuron</italic>
<volume>62</volume>
<fpage>670</fpage>‚Äì<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.04.023</pub-id>
<pub-id pub-id-type="pmid">19524526</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Niwa</surname><given-names>F.</given-names></name><name><surname>Sherwood</surname><given-names>M. W.</given-names></name><name><surname>Shrivastava</surname><given-names>A. N.</given-names></name><name><surname>Arizono</surname><given-names>M.</given-names></name><name><surname>Miyamoto</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Bidirectional control of synaptic GABAAR clustering by glutamate and calcium.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>13</volume>
<fpage>2768</fpage>‚Äì<lpage>2780</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.002</pub-id>
<pub-id pub-id-type="pmid">26711343</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battaglia</surname><given-names>S.</given-names></name><name><surname>Renner</surname><given-names>M.</given-names></name><name><surname>Russeau</surname><given-names>M.</given-names></name><name><surname>Come</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Activity-dependent inhibitory synapse scaling is determined by gephyrin phosphorylation and subsequent regulation of GABAA receptor diffusion.</article-title>
<source/><italic>eNeuro</italic>
<volume>5</volume>:<issue>ENEURO.0203-17.2017</issue>. <pub-id pub-id-type="doi">10.1523/eneuro.0203-17.2017</pub-id>
<pub-id pub-id-type="pmid">29379879</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baulac</surname><given-names>S.</given-names></name><name><surname>Huberfeld</surname><given-names>G.</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I.</given-names></name><name><surname>Mitropoulou</surname><given-names>G.</given-names></name><name><surname>Beranger</surname><given-names>A.</given-names></name><name><surname>Prud‚Äôhomme</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>28</volume>
<fpage>46</fpage>‚Äì<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/88254</pub-id>
<pub-id pub-id-type="pmid">11326274</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>C. A.</given-names></name><name><surname>Petrovski</surname><given-names>S.</given-names></name><name><surname>Oliver</surname><given-names>K. L.</given-names></name><name><surname>Berkovic</surname><given-names>S. F.</given-names></name></person-group> (<year>2017</year>). <article-title>ExACtly zero or once: a clinically helpful guide to assessing genetic variants in mild epilepsies.</article-title>
<source/><italic>Neurol. Genet.</italic>
<volume>3</volume>:<issue>e163</issue>. <pub-id pub-id-type="doi">10.1212/NXG.0000000000000163</pub-id>
<pub-id pub-id-type="pmid">28717674</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>M. T.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Two different mechanisms of disinhibition produced by GABA(A) receptor mutations linked to epilepsy in humans.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>5321</fpage>‚Äì<lpage>5327</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-13-05321.2002</pub-id>
<pub-id pub-id-type="pmid">12097483</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>Y.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Armstrong-Gold</surname><given-names>C.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name><name><surname>Lindstrom</surname><given-names>J.</given-names></name><name><surname>Pangalos</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts.</article-title>
<source/><italic>EMBO J.</italic>
<volume>25</volume>
<fpage>4381</fpage>‚Äì<lpage>4389</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601309</pub-id>
<pub-id pub-id-type="pmid">16946701</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boileau</surname><given-names>A. J.</given-names></name><name><surname>Pearce</surname><given-names>R. A.</given-names></name><name><surname>Czajkowski</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>The short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>4895</fpage>‚Äì<lpage>4903</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5039-09.2010</pub-id>
<pub-id pub-id-type="pmid">20371809</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boillot</surname><given-names>M.</given-names></name><name><surname>Morin-Brureau</surname><given-names>M.</given-names></name><name><surname>Picard</surname><given-names>F.</given-names></name><name><surname>Weckhuysen</surname><given-names>S.</given-names></name><name><surname>Lambrecq</surname><given-names>V.</given-names></name><name><surname>Minetti</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Novel GABRG2 mutations cause familial febrile seizures.</article-title>
<source/><italic>Neurol. Genet.</italic>
<volume>1</volume>:<issue>e35</issue>. <pub-id pub-id-type="doi">10.1212/NXG.0000000000000035</pub-id>
<pub-id pub-id-type="pmid">27066572</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouthour</surname><given-names>W.</given-names></name><name><surname>Leroy</surname><given-names>F.</given-names></name><name><surname>Emmanuelli</surname><given-names>C.</given-names></name><name><surname>Carnaud</surname><given-names>M.</given-names></name><name><surname>Dahan</surname><given-names>M.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A human mutation in Gabrg2 associated with generalized epilepsy alters the membrane dynamics of GABAA receptors.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>22</volume>
<fpage>1542</fpage>‚Äì<lpage>1553</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr225</pub-id>
<pub-id pub-id-type="pmid">21908847</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowser</surname><given-names>D. N.</given-names></name><name><surname>Wagner</surname><given-names>D. A.</given-names></name><name><surname>Czajkowski</surname><given-names>C.</given-names></name><name><surname>Cromer</surname><given-names>B. A.</given-names></name><name><surname>Parker</surname><given-names>M. W.</given-names></name><name><surname>Wallace</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>99</volume>
<fpage>15170</fpage>‚Äì<lpage>15175</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.212320199</pub-id>
<pub-id pub-id-type="pmid">12415111</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>M. L.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Synaptic localization of alpha5 GABA (A) receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>75</volume>
<fpage>1241</fpage>‚Äì<lpage>1251</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22280</pub-id>
<pub-id pub-id-type="pmid">25663431</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandon</surname><given-names>N.</given-names></name><name><surname>Jovanovic</surname><given-names>J.</given-names></name><name><surname>Moss</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>94</volume>
<fpage>113</fpage>‚Äì<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-7258(02)00175-4</pub-id>
<pub-id pub-id-type="pmid">12191597</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Delmas</surname><given-names>P.</given-names></name><name><surname>Hill</surname><given-names>J.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Constitutive tyrosine phosphorylation of the GABA(A) receptor gamma 2 subunit in rat brain.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>41</volume>
<fpage>745</fpage>‚Äì<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(01)00121-6</pub-id>
<pub-id pub-id-type="pmid">11640929</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Jovanovic</surname><given-names>J. N.</given-names></name><name><surname>Colledge</surname><given-names>M.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Brandon</surname><given-names>J. M.</given-names></name><name><surname>Scott</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABA(A) receptors by cAMP-dependent protein kinase via selective interaction with receptor beta subunits.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>22</volume>
<fpage>87</fpage>‚Äì<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/S1044-7431(02)00017-9</pub-id>
<pub-id pub-id-type="pmid">12595241</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>G. P.</given-names></name><name><surname>Jimenez-Mateos</surname><given-names>E. M.</given-names></name><name><surname>McKiernan</surname><given-names>R. C.</given-names></name><name><surname>Engel</surname><given-names>T.</given-names></name><name><surname>Tzivion</surname><given-names>G.</given-names></name><name><surname>Henshall</surname><given-names>D. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivo.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e54491</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0054491</pub-id>
<pub-id pub-id-type="pmid">23359526</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buhr</surname><given-names>A.</given-names></name><name><surname>Baur</surname><given-names>R.</given-names></name><name><surname>Sigel</surname><given-names>E.</given-names></name></person-group> (<year>1997</year>). <article-title>Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>272</volume>
<fpage>11799</fpage>‚Äì<lpage>11804</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.18.11799</pub-id>
<pub-id pub-id-type="pmid">9115236</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagetti</surname><given-names>E.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Spigelman</surname><given-names>I.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>63</volume>
<fpage>53</fpage>‚Äì<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1124/mol.63.1.53</pub-id>
<pub-id pub-id-type="pmid">12488536</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname><given-names>G. L.</given-names></name><name><surname>Heavin</surname><given-names>S. B.</given-names></name><name><surname>Yendle</surname><given-names>S. C.</given-names></name><name><surname>McMahon</surname><given-names>J. M.</given-names></name><name><surname>O‚ÄôRoak</surname><given-names>B. J.</given-names></name><name><surname>Cook</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>45</volume>
<fpage>825</fpage>‚Äì<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2646</pub-id>
<pub-id pub-id-type="pmid">23708187</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>D.</given-names></name><name><surname>Korpi</surname><given-names>E. R.</given-names></name><name><surname>Miralles</surname><given-names>C. P.</given-names></name><name><surname>De Blas</surname><given-names>A. L.</given-names></name><name><surname>Homanics</surname><given-names>G. E.</given-names></name></person-group> (<year>2005</year>). <article-title>GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines.</article-title>
<source/><italic>BMC Neurosci.</italic>
<volume>6</volume>:<issue>30</issue>. <pub-id pub-id-type="doi">10.1186/1471-2202-6-30</pub-id>
<pub-id pub-id-type="pmid">15850489</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaumont</surname><given-names>S.</given-names></name><name><surname>Andre</surname><given-names>C.</given-names></name><name><surname>Perrais</surname><given-names>D.</given-names></name><name><surname>Boue-Grabot</surname><given-names>E.</given-names></name><name><surname>Taly</surname><given-names>A.</given-names></name><name><surname>Garret</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Agonist-dependent endocytosis of gamma-aminobutyric acid type A (GABAA) receptors revealed by a gamma2(R43Q) epilepsy mutation.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>28254</fpage>‚Äì<lpage>28265</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.470807</pub-id>
<pub-id pub-id-type="pmid">23935098</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y.</given-names></name><name><surname>Sims</surname><given-names>G. E.</given-names></name><name><surname>Murphy</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>J. R.</given-names></name><name><surname>Chan</surname><given-names>A. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Predicting the functional effect of amino acid substitutions and indels.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e46688</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id>
<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>W. H.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>McMahon</surname><given-names>T.</given-names></name><name><surname>Qi</surname><given-names>Z. H.</given-names></name><name><surname>Song</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>GABAA receptor trafficking is regulated by protein kinase C(epsilon) and the N-ethylmaleimide-sensitive factor.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>13955</fpage>‚Äì<lpage>13965</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0270-10.2010</pub-id>
<pub-id pub-id-type="pmid">20962217</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinar</surname><given-names>H.</given-names></name><name><surname>Barnes</surname><given-names>E. M.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2001</year>). <article-title>Clathrin-independent endocytosis of GABA(A) receptors in HEK 293 cells.</article-title>
<source/><italic>Biochemistry</italic>
<volume>40</volume>
<fpage>14030</fpage>‚Äì<lpage>14036</lpage>. <pub-id pub-id-type="doi">10.1021/bi011025t</pub-id>
<pub-id pub-id-type="pmid">11705395</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>C. N.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Uren</surname><given-names>J. M.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Cell surface stability of gamma-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>274</volume>
<fpage>36565</fpage>‚Äì<lpage>36572</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.51.36565</pub-id>
<pub-id pub-id-type="pmid">10593956</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crestani</surname><given-names>F.</given-names></name><name><surname>Lorez</surname><given-names>M.</given-names></name><name><surname>Baer</surname><given-names>K.</given-names></name><name><surname>Essrich</surname><given-names>C.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Laurent</surname><given-names>J. P.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>2</volume>
<fpage>833</fpage>‚Äì<lpage>839</lpage>. <pub-id pub-id-type="doi">10.1038/12207</pub-id>
<pub-id pub-id-type="pmid">10461223</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname><given-names>E. C.</given-names></name><name><surname>Pendolino</surname><given-names>V.</given-names></name><name><surname>Kontou</surname><given-names>G.</given-names></name><name><surname>McGee</surname><given-names>T. P.</given-names></name><name><surname>Sheehan</surname><given-names>D. F.</given-names></name><name><surname>Lopez-Domenech</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>An essential role for the tetraspanin LHFPL4 in the cell-type-specific targeting and clustering of synaptic GABAA receptors.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>21</volume>
<fpage>70</fpage>‚Äì<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.025</pub-id>
<pub-id pub-id-type="pmid">28978485</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Luca</surname><given-names>E.</given-names></name><name><surname>Ravasenga</surname><given-names>T.</given-names></name><name><surname>Petrini</surname><given-names>E. M.</given-names></name><name><surname>Polenghi</surname><given-names>A.</given-names></name><name><surname>Nieus</surname><given-names>T.</given-names></name><name><surname>Guazzi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Inter-synaptic lateral diffusion of GABAA receptors shapes inhibitory synaptic currents.</article-title>
<source/><italic>Neuron</italic>
<volume>95</volume>
<fpage>63</fpage>‚Äì<lpage>69</lpage>.<issue>e5</issue>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.022</pub-id>
<pub-id pub-id-type="pmid">28683270</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Mina</surname><given-names>E.</given-names></name><name><surname>Ciccone</surname><given-names>R.</given-names></name><name><surname>Brustia</surname><given-names>F.</given-names></name><name><surname>Bayindir</surname><given-names>B.</given-names></name><name><surname>Limongelli</surname><given-names>I.</given-names></name><name><surname>Vetro</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>23</volume>
<fpage>354</fpage>‚Äì<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2014.92</pub-id>
<pub-id pub-id-type="pmid">24848745</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>H. J.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name><name><surname>Botzolakis</surname><given-names>E. J.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Gallagher</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>
<fpage>26390</fpage>‚Äì<lpage>26405</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.142299</pub-id>
<pub-id pub-id-type="pmid">20551311</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>J. T.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Markov</surname><given-names>G. J.</given-names></name><name><surname>Gerold</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Human genomic disease variants: a neutral evolutionary explanation.</article-title>
<source/><italic>Genome Res.</italic>
<volume>22</volume>
<fpage>1383</fpage>‚Äì<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1101/gr.133702.111</pub-id>
<pub-id pub-id-type="pmid">22665443</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earnheart</surname><given-names>J. C.</given-names></name><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Crestani</surname><given-names>F.</given-names></name><name><surname>Iwasato</surname><given-names>T.</given-names></name><name><surname>Itohara</surname><given-names>S.</given-names></name><name><surname>Mohler</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>3845</fpage>‚Äì<lpage>3854</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3609-06.2007</pub-id>
<pub-id pub-id-type="pmid">17409249</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>C.</given-names></name><name><surname>Hahnen</surname><given-names>E.</given-names></name><name><surname>Engel</surname><given-names>C.</given-names></name><name><surname>Nothnagel</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>J.</given-names></name><name><surname>Schmutzler</surname><given-names>R. K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Performance of <italic>in silico</italic> prediction tools for the classification of rare <italic>BRCA1/2</italic> missense variants in clinical diagnostics.</article-title>
<source/><italic>BMC Med. Genomics</italic>
<volume>11</volume>:<issue>35</issue>. <pub-id pub-id-type="doi">10.1186/s12920-018-0353-y</pub-id>
<pub-id pub-id-type="pmid">29580235</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eugene</surname><given-names>E.</given-names></name><name><surname>Depienne</surname><given-names>C.</given-names></name><name><surname>Baulac</surname><given-names>S.</given-names></name><name><surname>Baulac</surname><given-names>M.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Le Guern</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>GABA(A) receptor gamma 2 subunit mutations linked to human epileptic syndromes differentially affect phasic and tonic inhibition.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>14108</fpage>‚Äì<lpage>14116</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2618-07.2007</pub-id>
<pub-id pub-id-type="pmid">18094250</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>L.</given-names></name><name><surname>Keller</surname><given-names>C. A.</given-names></name><name><surname>Fukata</surname><given-names>M.</given-names></name><name><surname>Fukata</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>GODZ-mediated palmitoylation of GABA(A) receptors is required for normal assembly and function of GABAergic inhibitory synapses.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>12758</fpage>‚Äì<lpage>12768</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4214-06.2006</pub-id>
<pub-id pub-id-type="pmid">17151279</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name></person-group> (<year>2001</year>). <article-title>Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>21</volume>
<fpage>6502</fpage>‚Äì<lpage>6511</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-17-06502.2001</pub-id>
<pub-id pub-id-type="pmid">11517239</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>G. W.</given-names></name><name><surname>Adler</surname><given-names>S. A.</given-names></name><name><surname>Fuhrman</surname><given-names>M. H.</given-names></name><name><surname>Waggoner</surname><given-names>A. S.</given-names></name><name><surname>Bruchez</surname><given-names>M. P.</given-names></name><name><surname>Jarvik</surname><given-names>J. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Detection and quantification of beta2AR internalization in living cells using FAP-based biosensor technology.</article-title>
<source/><italic>J. Biomol. Screen.</italic>
<volume>15</volume>
<fpage>703</fpage>‚Äì<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1177/1087057110370892</pub-id>
<pub-id pub-id-type="pmid">20488980</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>R. S.</given-names></name><name><surname>Cross</surname><given-names>J. H.</given-names></name><name><surname>French</surname><given-names>J. A.</given-names></name><name><surname>Higurashi</surname><given-names>N.</given-names></name><name><surname>Hirsch</surname><given-names>E.</given-names></name><name><surname>Jansen</surname><given-names>F. E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology.</article-title>
<source/><italic>Epilepsia</italic>
<volume>58</volume>
<fpage>522</fpage>‚Äì<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13670</pub-id>
<pub-id pub-id-type="pmid">28276060</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromer</surname><given-names>M.</given-names></name><name><surname>Pocklington</surname><given-names>A. J.</given-names></name><name><surname>Kavanagh</surname><given-names>D. H.</given-names></name><name><surname>Williams</surname><given-names>H. J.</given-names></name><name><surname>Dwyer</surname><given-names>S.</given-names></name><name><surname>Gormley</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>De novo mutations in schizophrenia implicate synaptic networks.</article-title>
<source/><italic>Nature</italic>
<volume>506</volume>
<fpage>179</fpage>‚Äì<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nature12929</pub-id>
<pub-id pub-id-type="pmid">24463507</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frugier</surname><given-names>G.</given-names></name><name><surname>Coussen</surname><given-names>F.</given-names></name><name><surname>Giraud</surname><given-names>M. F.</given-names></name><name><surname>Odessa</surname><given-names>M. F.</given-names></name><name><surname>Emerit</surname><given-names>M. B.</given-names></name><name><surname>Boue-Grabot</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A gamma 2(R43Q) mutation, linked to epilepsy in humans, alters GABAA receptor assembly and modifies subunit composition on the cell surface.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>282</volume>
<fpage>3819</fpage>‚Äì<lpage>3828</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M608910200</pub-id>
<pub-id pub-id-type="pmid">17148443</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>Y.</given-names></name><name><surname>Cassidy</surname><given-names>R. M.</given-names></name><name><surname>Moon</surname><given-names>K. M.</given-names></name><name><surname>Lewis</surname><given-names>R.</given-names></name><name><surname>Wong</surname><given-names>R. O. L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Clptm1 limits forward trafficking of GABAA receptors to scale inhibitory synaptic strength.</article-title>
<source/><italic>Neuron</italic>
<volume>97</volume>
<fpage>596</fpage>‚Äì<lpage>610</lpage>.e8. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.12.038</pub-id>
<pub-id pub-id-type="pmid">29395912</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>GABAA receptor subunit composition and competition at synapses are tuned by GABAB receptor activity.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>60</volume>
<fpage>97</fpage>‚Äì<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2014.04.001</pub-id>
<pub-id pub-id-type="pmid">24747870</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>H.</given-names></name><name><surname>Auguadri</surname><given-names>L.</given-names></name><name><surname>Battaglia</surname><given-names>S.</given-names></name><name><surname>Simone Thirouin</surname><given-names>Z.</given-names></name><name><surname>Zemoura</surname><given-names>K.</given-names></name><name><surname>Messner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Several posttranslational modifications act in concert to regulate gephyrin scaffolding and GABAergic transmission.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>13365</issue>. <pub-id pub-id-type="doi">10.1038/ncomms13365</pub-id>
<pub-id pub-id-type="pmid">27819299</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>C.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Ethanol promotes clathrin adaptor-mediated endocytosis via the intracellular domain of delta-containing GABAA receptors.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>17874</fpage>‚Äì<lpage>17881</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2535-12.2012</pub-id>
<pub-id pub-id-type="pmid">23223306</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodkin</surname><given-names>H. P.</given-names></name><name><surname>Joshi</surname><given-names>S.</given-names></name><name><surname>Mtchedlishvili</surname><given-names>Z.</given-names></name><name><surname>Brar</surname><given-names>J.</given-names></name><name><surname>Kapur</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Subunit-specific trafficking of GABA(A) receptors during status epilepticus.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>2527</fpage>‚Äì<lpage>2538</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3426-07.2008</pub-id><pub-id pub-id-type="pmid">18322097</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodkin</surname><given-names>H. P.</given-names></name><name><surname>Yeh</surname><given-names>J. L.</given-names></name><name><surname>Kapur</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Status epilepticus increases the intracellular accumulation of GABAA receptors.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>5511</fpage>‚Äì<lpage>5520</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0900-05.2005</pub-id>
<pub-id pub-id-type="pmid">15944379</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>H.</given-names></name><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Misumi</surname><given-names>Y.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Hirata</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Direct interaction of N-ethylmaleimide-sensitive factor with GABA(A) receptor beta subunits.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>30</volume>
<fpage>197</fpage>‚Äì<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2005.07.006</pub-id>
<pub-id pub-id-type="pmid">16095914</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouzer</surname><given-names>G.</given-names></name><name><surname>Specht</surname><given-names>C. G.</given-names></name><name><surname>Allain</surname><given-names>L.</given-names></name><name><surname>Shinoe</surname><given-names>T.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Benzodiazepine-dependent stabilization of GABA(A) receptors at synapses.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>63</volume>
<fpage>101</fpage>‚Äì<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2014.10.004</pub-id>
<pub-id pub-id-type="pmid">25466558</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>G. G.</given-names></name><name><surname>Junge</surname><given-names>J. A.</given-names></name><name><surname>Mora</surname><given-names>R. J.</given-names></name><name><surname>Kwon</surname><given-names>H. B.</given-names></name><name><surname>Olson</surname><given-names>C. A.</given-names></name><name><surname>Takahashi</surname><given-names>T. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Recombinant probes for visualizing endogenous synaptic proteins in living neurons.</article-title>
<source/><italic>Neuron</italic>
<volume>78</volume>
<fpage>971</fpage>‚Äì<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.04.017</pub-id>
<pub-id pub-id-type="pmid">23791193</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>G. G.</given-names></name><name><surname>Straub</surname><given-names>C.</given-names></name><name><surname>Perez-Sanchez</surname><given-names>J.</given-names></name><name><surname>Dempsey</surname><given-names>W. P.</given-names></name><name><surname>Junge</surname><given-names>J. A.</given-names></name><name><surname>Roberts</surname><given-names>R. W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>An E3-ligase-based method for ablating inhibitory synapses.</article-title>
<source/><italic>Nat Methods</italic>
<volume>13</volume>
<fpage>673</fpage>‚Äì<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3894</pub-id>
<pub-id pub-id-type="pmid">27271196</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grover</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>B. F.</given-names></name><name><surname>Salter</surname><given-names>R. D.</given-names></name><name><surname>Watkins</surname><given-names>S. C.</given-names></name><name><surname>Waggoner</surname><given-names>A. S.</given-names></name><name><surname>Bruchez</surname><given-names>M. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Genetically encoded pH sensor for tracking surface proteins through endocytosis.</article-title>
<source/><italic>Angew. Chem. Int. Ed. Engl.</italic>
<volume>51</volume>
<fpage>4838</fpage>‚Äì<lpage>4842</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201108107</pub-id>
<pub-id pub-id-type="pmid">22461279</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Chiu</surname><given-names>S. L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>P. H.</given-names></name><name><surname>Delannoy</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>D. T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Differential vesicular sorting of AMPA and GABAA receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E922</fpage>‚Äì<lpage>E931</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1525726113</pub-id>
<pub-id pub-id-type="pmid">26839408</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunther</surname><given-names>U.</given-names></name><name><surname>Benson</surname><given-names>J.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Reyes</surname><given-names>G.</given-names></name><name><surname>Knoflach</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>92</volume>
<fpage>7749</fpage>‚Äì<lpage>7753</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.17.7749</pub-id>
<pub-id pub-id-type="pmid">7644489</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>M. L.</given-names></name><name><surname>Ferreri</surname><given-names>M. C.</given-names></name><name><surname>Gravielle</surname><given-names>M. C.</given-names></name></person-group> (<year>2014</year>). <article-title>GABA-induced uncoupling of GABA/benzodiazepine site interactions is mediated by increased GABAA receptor internalization and associated with a change in subunit composition.</article-title>
<source/><italic>Neuroscience</italic>
<volume>257</volume>
<fpage>119</fpage>‚Äì<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.10.077</pub-id>
<pub-id pub-id-type="pmid">24215979</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harkin</surname><given-names>L. A.</given-names></name><name><surname>Bowser</surname><given-names>D. N.</given-names></name><name><surname>Dibbens</surname><given-names>L. M.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Phillips</surname><given-names>F.</given-names></name><name><surname>Wallace</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>70</volume>
<fpage>530</fpage>‚Äì<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1086/338710</pub-id>
<pub-id pub-id-type="pmid">11748509</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassaine</surname><given-names>G.</given-names></name><name><surname>Deluz</surname><given-names>C.</given-names></name><name><surname>Grasso</surname><given-names>L.</given-names></name><name><surname>Wyss</surname><given-names>R.</given-names></name><name><surname>Tol</surname><given-names>M. B.</given-names></name><name><surname>Hovius</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>X-ray structure of the mouse serotonin 5-HT3 receptor.</article-title>
<source/><italic>Nature</italic>
<volume>512</volume>
<fpage>276</fpage>‚Äì<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1038/nature13552</pub-id>
<pub-id pub-id-type="pmid">25119048</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Muhia</surname><given-names>M.</given-names></name><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Hirdes</surname><given-names>W.</given-names></name><name><surname>Tsukita</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>6</volume>:<issue>6872</issue>. <pub-id pub-id-type="doi">10.1038/ncomms7872</pub-id>
<pub-id pub-id-type="pmid">25891999</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Missinato</surname><given-names>M. A.</given-names></name><name><surname>Onuoha</surname><given-names>E.</given-names></name><name><surname>Perkins</surname><given-names>L. A.</given-names></name><name><surname>Watkins</surname><given-names>S. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A genetically targetable near-infrared photosensitizer.</article-title>
<source/><italic>Nat. Methods</italic>
<volume>13</volume>
<fpage>263</fpage>‚Äì<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3735</pub-id>
<pub-id pub-id-type="pmid">26808669</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Klassen</surname><given-names>T. L.</given-names></name><name><surname>Jackson</surname><given-names>L. G.</given-names></name><name><surname>Gurba</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Deleterious rare variants reveal risk for loss of GABAA receptor function in patients with genetic epilepsy and in the general population.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0162883</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0162883</pub-id>
<pub-id pub-id-type="pmid">27870904</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Kong</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Jackson</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Altered channel conductance states and gating of GABAA receptors by a pore mutation linked to Dravet syndrome.</article-title>
<source/><italic>eNeuro</italic>
<volume>4</volume>:<issue>ENEURO.0251-16.2017</issue>. <pub-id pub-id-type="doi">10.1523/ENEURO.0251-16.2017</pub-id>
<pub-id pub-id-type="pmid">28197552</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herring</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Dillon</surname><given-names>G. H.</given-names></name><name><surname>Leidenheimer</surname><given-names>N. J.</given-names></name></person-group> (<year>2005</year>). <article-title>PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor beta 2 subunit.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>48</volume>
<fpage>181</fpage>‚Äì<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.09.015</pub-id>
<pub-id pub-id-type="pmid">15695157</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Davies</surname><given-names>P. A.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Maguire</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional regulation of GABAA receptors in nervous system pathologies.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>22</volume>
<fpage>552</fpage>‚Äì<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2011.10.007</pub-id>
<pub-id pub-id-type="pmid">22036769</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>S.</given-names></name><name><surname>Mitsudome</surname><given-names>A.</given-names></name><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Kaneko</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Genetics of idiopathic epilepsies.</article-title>
<source/><italic>Epilepsia</italic>
<volume>46</volume>
<fpage>38</fpage>‚Äì<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/j.0013-9580.2005.461011.x</pub-id>
<pub-id pub-id-type="pmid">15816978</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homanics</surname><given-names>G. E.</given-names></name><name><surname>Harrison</surname><given-names>N. L.</given-names></name><name><surname>Quinlan</surname><given-names>J. J.</given-names></name><name><surname>Krasowski</surname><given-names>M. D.</given-names></name><name><surname>Rick</surname><given-names>C. E.</given-names></name><name><surname>de Blas</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptor.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>38</volume>
<fpage>253</fpage>‚Äì<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(98)00177-4</pub-id>
<pub-id pub-id-type="pmid">10218866</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Ng</surname><given-names>P. C.</given-names></name></person-group> (<year>2013</year>). <article-title>SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e77940</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0077940</pub-id>
<pub-id pub-id-type="pmid">24194902</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Three epilepsy-associated GABRG2 missense mutations at the gamma+/beta- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>68</volume>
<fpage>167</fpage>‚Äì<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.015</pub-id>
<pub-id pub-id-type="pmid">24798517</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>48</volume>
<fpage>115</fpage>‚Äì<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.06.013</pub-id>
<pub-id pub-id-type="pmid">22750526</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huntsman</surname><given-names>M. M.</given-names></name><name><surname>Tran</surname><given-names>B. V.</given-names></name><name><surname>Potkin</surname><given-names>S. G.</given-names></name><name><surname>Bunney</surname><given-names>W. E.</given-names></name><name><surname>Jones</surname><given-names>E. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>15066</fpage>‚Äì<lpage>15071</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.25.15066</pub-id>
<pub-id pub-id-type="pmid">9844016</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>A.</given-names></name><name><surname>Kanaumi</surname><given-names>T.</given-names></name><name><surname>Sohda</surname><given-names>M.</given-names></name><name><surname>Misumi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Kakinuma</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.</article-title>
<source/><italic>Epilepsy Res.</italic>
<volume>108</volume>
<fpage>420</fpage>‚Äì<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2013.12.005</pub-id>
<pub-id pub-id-type="pmid">24480790</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Bogdanov</surname><given-names>Y. D.</given-names></name><name><surname>Magnus</surname><given-names>C.</given-names></name><name><surname>Saliba</surname><given-names>R. S.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>10469</fpage>‚Äì<lpage>10478</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2267-05.2005</pub-id>
<pub-id pub-id-type="pmid">16280585</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Silayeva</surname><given-names>L.</given-names></name><name><surname>Haydon</surname><given-names>J.</given-names></name><name><surname>Succol</surname><given-names>F.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>18595</fpage>‚Äì<lpage>18600</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1204994109</pub-id>
<pub-id pub-id-type="pmid">23091016</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>J. J.</given-names></name><name><surname>Brouwer</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Lollipops in the clinic: information dense mutation plots for precision medicine.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0160519</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160519</pub-id>
<pub-id pub-id-type="pmid">27490490</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Chiou</surname><given-names>T. T.</given-names></name><name><surname>Serwanski</surname><given-names>D. R.</given-names></name><name><surname>Miralles</surname><given-names>C. P.</given-names></name><name><surname>Pinal</surname><given-names>N.</given-names></name><name><surname>De Blas</surname><given-names>A. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Ring finger protein 34 (RNF34) interacts with and promotes gamma-aminobutyric acid type-A receptor degradation via ubiquitination of the gamma2 subunit.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>29420</fpage>‚Äì<lpage>29436</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.603068</pub-id>
<pub-id pub-id-type="pmid">25193658</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>A. J.</given-names></name><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Pickrell</surname><given-names>W. O.</given-names></name><name><surname>Cushion</surname><given-names>T. D.</given-names></name><name><surname>Davies</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A novel GABRG2 mutation, p.R136<sup>‚àó</sup>, in a family with GEFS<sup>+</sup> and extended phenotypes.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>64</volume>
<fpage>131</fpage>‚Äì<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.12.013</pub-id>
<pub-id pub-id-type="pmid">24407264</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>S.</given-names></name><name><surname>Rajasekaran</surname><given-names>K.</given-names></name><name><surname>Hawk</surname><given-names>K. M.</given-names></name><name><surname>Brar</surname><given-names>J.</given-names></name><name><surname>Ross</surname><given-names>B. M.</given-names></name><name><surname>Tran</surname><given-names>C. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.</article-title>
<source/><italic>Epilepsia</italic>
<volume>56</volume>
<fpage>1355</fpage>‚Äì<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13098</pub-id>
<pub-id pub-id-type="pmid">26248944</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurd</surname><given-names>R.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Walker</surname><given-names>J.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Fyn kinase contributes to tyrosine phosphorylation of the GABA receptor gamma2 subunit.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>44</volume>
<fpage>129</fpage>‚Äì<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.03.002</pub-id>
<pub-id pub-id-type="pmid">20233604</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kananura</surname><given-names>C.</given-names></name><name><surname>Haug</surname><given-names>K.</given-names></name><name><surname>Sander</surname><given-names>T.</given-names></name><name><surname>Runge</surname><given-names>U.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Hallmann</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>A splice-site mutations in GABRG2 associated with childhood absence epilepsy and febrile convulsions.</article-title>
<source/><italic>Arch. Neurol.</italic>
<volume>59</volume>
<fpage>1137</fpage>‚Äì<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.59.7.1137</pub-id><pub-id pub-id-type="pmid">12117362</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Jang</surname><given-names>I. S.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Nagahama</surname><given-names>H.</given-names></name><name><surname>Yoshimura</surname><given-names>K.</given-names></name><name><surname>Hidaka</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Role of the PLC-related, catalytically inactive protein p130 in GABA(A) receptor function.</article-title>
<source/><italic>EMBO J.</italic>
<volume>21</volume>
<fpage>1004</fpage>‚Äì<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/21.5.1004</pub-id>
<pub-id pub-id-type="pmid">11867528</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2004</year>). <article-title>The GABAA receptor gamma2 subunit R43Q mutation linked to childhood absence epilepsy and febrile seizures causes retention of alpha1beta2gamma2S receptors in the endoplasmic reticulum.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>8672</fpage>‚Äì<lpage>8677</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2717-04.2004</pub-id>
<pub-id pub-id-type="pmid">15470132</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to Dravet syndrome.</article-title>
<source/><italic>JAMA Neurol.</italic>
<volume>73</volume>
<fpage>1009</fpage>‚Äì<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.0449</pub-id>
<pub-id pub-id-type="pmid">27367160</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>2590</fpage>‚Äì<lpage>2597</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4243-05.2006</pub-id>
<pub-id pub-id-type="pmid">16510738</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>2845</fpage>‚Äì<lpage>2856</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4772-08.2009</pub-id>
<pub-id pub-id-type="pmid">19261880</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>74</volume>
<fpage>547</fpage>‚Äì<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23947</pub-id>
<pub-id pub-id-type="pmid">23720301</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kano</surname><given-names>M.</given-names></name><name><surname>Kano</surname><given-names>M.</given-names></name><name><surname>Fukunaga</surname><given-names>K.</given-names></name><name><surname>Konnerth</surname><given-names>A.</given-names></name></person-group> (<year>1996</year>). <article-title>Ca(2+)-induced rebound potentiation of gamma-aminobutyric acid-mediated currents requires activation of Ca2+/calmodulin-dependent kinase II.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>93</volume>
<fpage>13351</fpage>‚Äì<lpage>13356</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.23.13351</pub-id>
<pub-id pub-id-type="pmid">8917594</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>S. Y.</given-names></name><name><surname>Hirano</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Sustained structural change of GABA(A) receptor-associated protein underlies long-term potentiation at inhibitory synapses on a cerebellar Purkinje neuron.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>6788</fpage>‚Äì<lpage>6799</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1981-07.2007</pub-id>
<pub-id pub-id-type="pmid">17581966</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C. A.</given-names></name><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>M. L.</given-names></name><name><surname>Alldred</surname><given-names>M.</given-names></name><name><surname>Sassoe-Pognetto</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>5881</fpage>‚Äì<lpage>5891</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1037-04.2004</pub-id><pub-id pub-id-type="pmid">15229235</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>C. L.</given-names></name><name><surname>Murakami</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Lal</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Dissociation of Golgi-associated DHHC-type zinc finger protein (GODZ)- and sertoli cell gene with a zinc finger domain-Œ≤ (SERZ-Œ≤)-mediated palmitoylation by loss of function analyses in knock-out mice.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>27371</fpage>‚Äì<lpage>27386</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.732768</pub-id>
<pub-id pub-id-type="pmid">27875292</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Honing</surname><given-names>S.</given-names></name><name><surname>Bogdanov</surname><given-names>Y.</given-names></name><name><surname>McAinsh</surname><given-names>K.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>102</volume>
<fpage>14871</fpage>‚Äì<lpage>14876</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506653102</pub-id>
<pub-id pub-id-type="pmid">16192353</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Kukhtina</surname><given-names>V.</given-names></name><name><surname>Vahedi-Faridi</surname><given-names>A.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor gamma2 subunit.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>3616</fpage>‚Äì<lpage>3621</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707920105</pub-id>
<pub-id pub-id-type="pmid">18305175</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Delmas</surname><given-names>P.</given-names></name><name><surname>Jovanovic</surname><given-names>J. N.</given-names></name><name><surname>Brown</surname><given-names>D. A.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>20</volume>
<fpage>7972</fpage>‚Äì<lpage>7977</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-21-07972.2000</pub-id>
<pub-id pub-id-type="pmid">11050117</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Bogdanov</surname><given-names>Y. D.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>12736</fpage>‚Äì<lpage>12741</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0401860101</pub-id>
<pub-id pub-id-type="pmid">15310851</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kneussel</surname><given-names>M.</given-names></name><name><surname>Brandstatter</surname><given-names>J. H.</given-names></name><name><surname>Laube</surname><given-names>B.</given-names></name><name><surname>Stahl</surname><given-names>S.</given-names></name><name><surname>Muller</surname><given-names>U.</given-names></name><name><surname>Betz</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>19</volume>
<fpage>9289</fpage>‚Äì<lpage>9297</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-21-09289.1999</pub-id><pub-id pub-id-type="pmid">10531433</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalczyk</surname><given-names>S.</given-names></name><name><surname>Winkelmann</surname><given-names>A.</given-names></name><name><surname>Smolinsky</surname><given-names>B.</given-names></name><name><surname>Forstera</surname><given-names>B.</given-names></name><name><surname>Neundorf</surname><given-names>I.</given-names></name><name><surname>Schwarz</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Direct binding of GABAA receptor beta2 and beta3 subunits to gephyrin.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>37</volume>
<fpage>544</fpage>‚Äì<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12078</pub-id>
<pub-id pub-id-type="pmid">23205938</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labonte</surname><given-names>D.</given-names></name><name><surname>Thies</surname><given-names>E.</given-names></name><name><surname>Kneussel</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>The kinesin KIF21B participates in the cell surface delivery of gamma2 subunit-containing GABAA receptors.</article-title>
<source/><italic>Eur. J. Cell Biol.</italic>
<volume>93</volume>
<fpage>338</fpage>‚Äì<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcb.2014.07.007</pub-id>
<pub-id pub-id-type="pmid">25172774</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachance-Touchette</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>P.</given-names></name><name><surname>Meloche</surname><given-names>C.</given-names></name><name><surname>Kinirons</surname><given-names>P.</given-names></name><name><surname>Lapointe</surname><given-names>L.</given-names></name><name><surname>Lacasse</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Novel alpha1 and gamma2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>34</volume>
<fpage>237</fpage>‚Äì<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07767.x</pub-id>
<pub-id pub-id-type="pmid">21714819</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Porteous</surname><given-names>R.</given-names></name><name><surname>Campbell</surname><given-names>R. E.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name><name><surname>Herbison</surname><given-names>A. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Knockdown of GABA(A) receptor signaling in GnRH neurons has minimal effects upon fertility.</article-title>
<source/><italic>Endocrinology</italic>
<volume>151</volume>
<fpage>4428</fpage>‚Äì<lpage>4436</lpage>. <pub-id pub-id-type="doi">10.1210/en.2010-0314</pub-id>
<pub-id pub-id-type="pmid">20573723</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leil</surname><given-names>T. A.</given-names></name><name><surname>Chen</surname><given-names>Z. W.</given-names></name><name><surname>Chang</surname><given-names>C. S.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>GABAA receptor-associated protein traffics GABAA receptors to the plasma membrane in neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>11429</fpage>‚Äì<lpage>11438</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3355-04.2004</pub-id>
<pub-id pub-id-type="pmid">15601949</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lek</surname><given-names>M.</given-names></name><name><surname>Karczewski</surname><given-names>K. J.</given-names></name><name><surname>Minikel</surname><given-names>E. V.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Banks</surname><given-names>E.</given-names></name><name><surname>Fennell</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Analysis of protein-coding genetic variation in 60,706 humans.</article-title>
<source/><italic>Nature</italic>
<volume>536</volume>
<fpage>285</fpage>‚Äì<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>I. U.</given-names></name><name><surname>Stuckey</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>D.</given-names></name><name><surname>Skinner</surname><given-names>J. R.</given-names></name><name><surname>Love</surname><given-names>D. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.</article-title>
<source/><italic>BMC Med. Genet.</italic>
<volume>16</volume>:<issue>34</issue>. <pub-id pub-id-type="doi">10.1186/s12881-015-0176-z</pub-id>
<pub-id pub-id-type="pmid">25967940</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leppa</surname><given-names>E.</given-names></name><name><surname>Linden</surname><given-names>A. M.</given-names></name><name><surname>Aller</surname><given-names>M. I.</given-names></name><name><surname>Wulff</surname><given-names>P.</given-names></name><name><surname>Vekovischeva</surname><given-names>O.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Increased motor-impairing effects of the neuroactive steroid pregnanolone in mice with targeted inactivation of the GABAA receptor gamma2 subunit in the cerebellum.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>7</volume>:<issue>403</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00403</pub-id>
<pub-id pub-id-type="pmid">27833556</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leppa</surname><given-names>E.</given-names></name><name><surname>Linden</surname><given-names>A. M.</given-names></name><name><surname>Vekovischeva</surname><given-names>O. Y.</given-names></name><name><surname>Swinny</surname><given-names>J. D.</given-names></name><name><surname>Rantanen</surname><given-names>V.</given-names></name><name><surname>Toppila</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Removal of GABA(A) receptor gamma2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e24159</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0024159</pub-id>
<pub-id pub-id-type="pmid">21912668</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>S.</given-names></name><name><surname>Le Roux</surname><given-names>N.</given-names></name><name><surname>Eugene</surname><given-names>E.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>88</volume>
<fpage>199</fpage>‚Äì<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.06.002</pub-id>
<pub-id pub-id-type="pmid">24930360</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W. C.</given-names></name><name><surname>Davenport</surname><given-names>C. M.</given-names></name><name><surname>Mourot</surname><given-names>A.</given-names></name><name><surname>Vytla</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>C. M.</given-names></name><name><surname>Medeiros</surname><given-names>K. A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Engineering a light-regulated GABAA receptor for optical control of neural inhibition.</article-title>
<source/><italic>ACS Chem. Biol.</italic>
<volume>9</volume>
<fpage>1414</fpage>‚Äì<lpage>1419</lpage>. <pub-id pub-id-type="doi">10.1021/cb500167u</pub-id>
<pub-id pub-id-type="pmid">24819442</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W.C.</given-names></name><name><surname>Tsai</surname><given-names>M.C.</given-names></name><name><surname>Davenport</surname><given-names>C.M.</given-names></name><name><surname>Smith</surname><given-names>C.M.</given-names></name><name><surname>Veit</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>N.M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A comprehensive optogenetic pharmacology toolkit for in vivo control of GABA(A) receptors and synaptic inhibition.</article-title>
<source/><italic>Neuron</italic>
<volume>88</volume>
<fpage>879</fpage>‚Äì<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.026</pub-id>
<pub-id pub-id-type="pmid">26606997</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Vaags</surname><given-names>A. K.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Gazzellone</surname><given-names>M. J.</given-names></name><name><surname>Mitchell</surname><given-names>E. B.</given-names></name><name><surname>Chen</surname><given-names>H. Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>2055</fpage>‚Äì<lpage>2066</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt056</pub-id>
<pub-id pub-id-type="pmid">23393157</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz-Guertin</surname><given-names>J. M.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name></person-group> (<year>2017</year>). <article-title>GABA type A receptor trafficking and the architecture of synaptic inhibition.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>78</volume>
<fpage>238</fpage>‚Äì<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22536</pub-id>
<pub-id pub-id-type="pmid">28901728</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz-Guertin</surname><given-names>J. M.</given-names></name><name><surname>Wilcox</surname><given-names>M. R.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Larsen</surname><given-names>M. B.</given-names></name><name><surname>Pilli</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>B. F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A versatile optical tool for studying synaptic GABA<sub>A</sub> receptor trafficking.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>130</volume>
<fpage>3933</fpage>‚Äì<lpage>3945</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.205286</pub-id>
<pub-id pub-id-type="pmid">29025969</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Marti-Gutierrez</surname><given-names>N.</given-names></name><name><surname>Park</surname><given-names>S. W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Correction of a pathogenic gene mutation in human embryos.</article-title>
<source/><italic>Nature</italic>
<volume>548</volume>
<fpage>413</fpage>‚Äì<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1038/nature23305</pub-id>
<pub-id pub-id-type="pmid">28783728</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>R. L.</given-names></name><name><surname>Bianch</surname><given-names>M. T.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Mutations linked to generalized epilepsy in humans reduce GABA(A) receptor current.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>184</volume>
<fpage>S58</fpage>‚Äì<lpage>S67</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-4886(03)00405-9</pub-id>
<pub-id pub-id-type="pmid">14597328</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>R. L.</given-names></name><name><surname>Kang</surname><given-names>J. -Q.</given-names></name><name><surname>Gallagher</surname><given-names>M. J.</given-names></name></person-group> (<year>2012</year>). <source/><italic>GABA(A) Receptor Subunit Mutations and Genetic Epilepsies.</italic>
<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information</publisher-name>.</mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maric</surname><given-names>H. M.</given-names></name><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Neubert</surname><given-names>F.</given-names></name><name><surname>Dalby</surname><given-names>N. O.</given-names></name><name><surname>Doose</surname><given-names>S.</given-names></name><name><surname>Sauer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Gephyrin-binding peptides visualize postsynaptic sites and modulate neurotransmission.</article-title>
<source/><italic>Nat. Chem. Biol.</italic>
<volume>13</volume>
<fpage>153</fpage>‚Äì<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2246</pub-id>
<pub-id pub-id-type="pmid">27893705</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsden</surname><given-names>K. C.</given-names></name><name><surname>Beattie</surname><given-names>J. B.</given-names></name><name><surname>Friedenthal</surname><given-names>J.</given-names></name><name><surname>Carroll</surname><given-names>R. C.</given-names></name></person-group> (<year>2007</year>). <article-title>NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABA(A) receptors.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>14326</fpage>‚Äì<lpage>14337</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4433-07.2007</pub-id>
<pub-id pub-id-type="pmid">18160640</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsden</surname><given-names>K. C.</given-names></name><name><surname>Shemesh</surname><given-names>A.</given-names></name><name><surname>Bayer</surname><given-names>K. U.</given-names></name><name><surname>Carroll</surname><given-names>R. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Selective translocation of Ca2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>20559</fpage>‚Äì<lpage>20564</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1010346107</pub-id>
<pub-id pub-id-type="pmid">21059908</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masica</surname><given-names>D.L.</given-names></name><name><surname>Karchin</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Towards increasing the clinical relevance of in silico methods to predict pathogenic missense variants.</article-title>
<source/><italic>PLoS Comput. Biol.</italic>
<volume>12</volume>:<issue>e1004725</issue>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004725</pub-id>
<pub-id pub-id-type="pmid">27171182</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>B. J.</given-names></name><name><surname>Amato</surname><given-names>A.</given-names></name><name><surname>Connolly</surname><given-names>C. N.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>1</volume>
<fpage>23</fpage>‚Äì<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/223</pub-id>
<pub-id pub-id-type="pmid">10195104</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>B. J.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Differential phosphorylation of intracellular domains of gamma-aminobutyric acid type A receptor subunits by calcium/calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>269</volume>
<fpage>18111</fpage>‚Äì<lpage>18117</lpage>. <pub-id pub-id-type="pmid">8027073</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>J.</given-names></name><name><surname>Grantyn</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Preferential accumulation of GABAA receptor gamma 2L, not gamma 2S, cytoplasmic loops at rat spinal cord inhibitory synapses.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>559(Pt 2)</volume>
<fpage>355</fpage>‚Äì<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.066233</pub-id>
<pub-id pub-id-type="pmid">15235089</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migita</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>J.</given-names></name><name><surname>Nikaido</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Kaneko</surname><given-names>S.</given-names></name><name><surname>Hirose</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Properties of a Novel GABAA receptor gamma2 subunit mutation associated with seizures.</article-title>
<source/><italic>J. Pharmacol. Sci.</italic>
<volume>121</volume>
<fpage>84</fpage>‚Äì<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.12222SC</pub-id><pub-id pub-id-type="pmid">23257655</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>P. S.</given-names></name><name><surname>Aricescu</surname><given-names>A. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Crystal structure of a human GABAA receptor.</article-title>
<source/><italic>Nature</italic>
<volume>512</volume>
<fpage>270</fpage>‚Äì<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1038/nature13293</pub-id>
<pub-id pub-id-type="pmid">24909990</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>P. S.</given-names></name><name><surname>Scott</surname><given-names>S.</given-names></name><name><surname>Masiulis</surname><given-names>S.</given-names></name><name><surname>De Colibus</surname><given-names>L.</given-names></name><name><surname>Pardon</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural basis for GABAA receptor potentiation by neurosteroids.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>24</volume>
<fpage>986</fpage>‚Äì<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3484</pub-id>
<pub-id pub-id-type="pmid">28991263</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizokami</surname><given-names>A.</given-names></name><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Ishibashi</surname><given-names>H.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Tanida</surname><given-names>I.</given-names></name><name><surname>Takenaka</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Phospholipase C-related inactive protein is involved in trafficking of gamma2 subunit-containing GABA(A) receptors to the cell surface.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>1692</fpage>‚Äì<lpage>1701</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3155-06.2007</pub-id>
<pub-id pub-id-type="pmid">17301177</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Doherty</surname><given-names>C. A.</given-names></name><name><surname>Huganir</surname><given-names>R. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Identification of the cAMP-dependent protein kinase and protein kinase C phosphorylation sites within the major intracellular domains of the beta 1, gamma 2S, and gamma 2L subunits of the gamma-aminobutyric acid type A receptor.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>267</volume>
<fpage>14470</fpage>‚Äì<lpage>14476</lpage>. <pub-id pub-id-type="pmid">1321150</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Gorrie</surname><given-names>G. H.</given-names></name><name><surname>Amato</surname><given-names>A.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Modulation of GABAA receptors by tyrosine phosphorylation.</article-title>
<source/><italic>Nature</italic>
<volume>377</volume>
<fpage>344</fpage>‚Äì<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/377344a0</pub-id>
<pub-id pub-id-type="pmid">7566089</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>MacAskill</surname><given-names>A. F.</given-names></name><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Griffin</surname><given-names>L. D.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2010</year>). <article-title>NMDA receptors regulate GABAA receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the gamma2 subunit.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>16679</fpage>‚Äì<lpage>16684</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1000589107</pub-id>
<pub-id pub-id-type="pmid">20823221</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Plasticity of GABAA receptor diffusion dynamics at the axon initial segment.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>151</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00151</pub-id>
<pub-id pub-id-type="pmid">24959118</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Kretschmannova</surname><given-names>K.</given-names></name><name><surname>Gouzer</surname><given-names>G.</given-names></name><name><surname>Maric</surname><given-names>H. M.</given-names></name><name><surname>Ramsden</surname><given-names>S.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The residence time of GABA(A)Rs at inhibitory synapses is determined by direct binding of the receptor alpha1 subunit to gephyrin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>14677</fpage>‚Äì<lpage>14687</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2001-11.2011</pub-id>
<pub-id pub-id-type="pmid">21994384</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>K.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Takei</surname><given-names>Y.</given-names></name><name><surname>Seog</surname><given-names>D. H.</given-names></name><name><surname>Homma</surname><given-names>N.</given-names></name><name><surname>Hirokawa</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular motor KIF5A is essential for GABA(A) receptor transport, and KIF5A deletion causes epilepsy.</article-title>
<source/><italic>Neuron</italic>
<volume>76</volume>
<fpage>945</fpage>‚Äì<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.10.012</pub-id>
<pub-id pub-id-type="pmid">23217743</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Arima-Yoshida</surname><given-names>F.</given-names></name><name><surname>Sakaue</surname><given-names>F.</given-names></name><name><surname>Nasu-Nishimura</surname><given-names>Y.</given-names></name><name><surname>Takeda</surname><given-names>Y.</given-names></name><name><surname>Matsuura</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>10861</issue>. <pub-id pub-id-type="doi">10.1038/ncomms10861</pub-id>
<pub-id pub-id-type="pmid">26979507</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Morrow</surname><given-names>D. H.</given-names></name><name><surname>Modgil</surname><given-names>A.</given-names></name><name><surname>Huyghe</surname><given-names>D.</given-names></name><name><surname>Deeb</surname><given-names>T. Z.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Proteomic characterization of inhibitory synapses using a novel pHluorin-tagged gamma-aminobutyric acid receptor, type A (GABAA), alpha2 subunit knock-in mouse.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>12394</fpage>‚Äì<lpage>12407</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.724443</pub-id>
<pub-id pub-id-type="pmid">27044742</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>D. E.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wasterlain</surname><given-names>C. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>7724</fpage>‚Äì<lpage>7733</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4944-04.2005</pub-id>
<pub-id pub-id-type="pmid">16120773</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemecz</surname><given-names>A.</given-names></name><name><surname>Prevost</surname><given-names>M. S.</given-names></name><name><surname>Menny</surname><given-names>A.</given-names></name><name><surname>Corringer</surname><given-names>P. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels.</article-title>
<source/><italic>Neuron</italic>
<volume>90</volume>
<fpage>452</fpage>‚Äì<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.032</pub-id>
<pub-id pub-id-type="pmid">27151638</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>F.</given-names></name><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Arizono</surname><given-names>M.</given-names></name><name><surname>Fukatsu</surname><given-names>K.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Mikoshiba</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Gephyrin-independent GABA(A)R mobility and clustering during plasticity.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e36148</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0036148</pub-id>
<pub-id pub-id-type="pmid">22563445</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>W. C.</given-names></name><name><surname>Lutzu</surname><given-names>S.</given-names></name><name><surname>Castillo</surname><given-names>P. E.</given-names></name><name><surname>Kwon</surname><given-names>H. B.</given-names></name></person-group> (<year>2016</year>). <article-title>De novo synaptogenesis induced by GABA in the developing mouse cortex.</article-title>
<source/><italic>Science</italic>
<volume>353</volume>
<fpage>1037</fpage>‚Äì<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf5206</pub-id>
<pub-id pub-id-type="pmid">27516412</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>R. W.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name></person-group> (<year>2009</year>). <article-title>GABA A receptors: subtypes provide diversity of function and pharmacology.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>56</volume>
<fpage>141</fpage>‚Äì<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.07.045</pub-id>
<pub-id pub-id-type="pmid">18760291</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O‚ÄôSullivan</surname><given-names>G. A.</given-names></name><name><surname>Kneussel</surname><given-names>M.</given-names></name><name><surname>Elazar</surname><given-names>Z.</given-names></name><name><surname>Betz</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>GABARAP is not essential for GABA receptor targeting to the synapse.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>22</volume>
<fpage>2644</fpage>‚Äì<lpage>2648</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04448.x</pub-id>
<pub-id pub-id-type="pmid">16307606</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennacchietti</surname><given-names>F.</given-names></name><name><surname>Vascon</surname><given-names>S.</given-names></name><name><surname>Nieus</surname><given-names>T.</given-names></name><name><surname>Rosillo</surname><given-names>C.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Nanoscale molecular reorganization of the inhibitory postsynaptic density is a determinant of GABAergic synaptic potentiation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>1747</fpage>‚Äì<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0514-16.2016</pub-id>
<pub-id pub-id-type="pmid">28073939</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>J.</given-names></name><name><surname>Sapp</surname><given-names>D. W.</given-names></name><name><surname>Tyndale</surname><given-names>R. F.</given-names></name><name><surname>Park</surname><given-names>M. K.</given-names></name><name><surname>Fanselow</surname><given-names>M.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Altered gabaa receptor subunit and splice variant expression in rats treated with chronic intermittent ethanol.</article-title>
<source/><italic>Alcohol. Clin. Exp. Res.</italic>
<volume>25</volume>
<fpage>819</fpage>‚Äì<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2001.tb02285.x</pub-id>
<pub-id pub-id-type="pmid">11410716</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrini</surname><given-names>E. M.</given-names></name><name><surname>Ravasenga</surname><given-names>T.</given-names></name><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Iurilli</surname><given-names>G.</given-names></name><name><surname>Olcese</surname><given-names>U.</given-names></name><name><surname>Racine</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic recruitment of gephyrin regulates surface GABAA receptor dynamics for the expression of inhibitory LTP.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>3921</issue>. <pub-id pub-id-type="doi">10.1038/ncomms4921</pub-id>
<pub-id pub-id-type="pmid">24894704</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulopoulos</surname><given-names>A.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Meyer</surname><given-names>G.</given-names></name><name><surname>Soykan</surname><given-names>T.</given-names></name><name><surname>Hoon</surname><given-names>M.</given-names></name><name><surname>Papadopoulos</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin.</article-title>
<source/><italic>Neuron</italic>
<volume>63</volume>
<fpage>628</fpage>‚Äì<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.023</pub-id>
<pub-id pub-id-type="pmid">19755106</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Z. H.</given-names></name><name><surname>Song</surname><given-names>M.</given-names></name><name><surname>Wallace</surname><given-names>M. J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Newton</surname><given-names>P. M.</given-names></name><name><surname>McMahon</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2 subunits.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>282</volume>
<fpage>33052</fpage>‚Äì<lpage>33063</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M707233200</pub-id>
<pub-id pub-id-type="pmid">17875639</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Z.</given-names></name><name><surname>Micorescu</surname><given-names>M.</given-names></name><name><surname>Yakhnitsa</surname><given-names>V.</given-names></name><name><surname>Barmack</surname><given-names>N. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Climbing fiber activity reduces 14-3-3-theta regulated GABA(A) receptor phosphorylation in cerebellar Purkinje cells.</article-title>
<source/><italic>Neuroscience</italic>
<volume>201</volume>
<fpage>34</fpage>‚Äì<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.11.021</pub-id>
<pub-id pub-id-type="pmid">22119642</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Z.</given-names></name><name><surname>Yakhnitsa</surname><given-names>V.</given-names></name><name><surname>Barmack</surname><given-names>N. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Climbing fiber-evoked Purkinje cell discharge reduces expression of GABA(A) receptor-associated protein and decreases its interaction with GABA(A) receptors.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>117</volume>
<fpage>197</fpage>‚Äì<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.07119.x</pub-id>
<pub-id pub-id-type="pmid">21105873</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>J. J.</given-names></name><name><surname>Firestone</surname><given-names>L. L.</given-names></name><name><surname>Homanics</surname><given-names>G. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Mice lacking the long splice variant of the gamma 2 subunit of the GABA(A) receptor are more sensitive to benzodiazepines.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>66</volume>
<fpage>371</fpage>‚Äì<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-3057(00)00225-2</pub-id>
<pub-id pub-id-type="pmid">10880692</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name><name><surname>Hess</surname><given-names>G. P.</given-names></name></person-group> (<year>2004</year>). <article-title>On the mechanism of a mutated and abnormally functioning Œ≥-aminobutyric acid (A) receptor linked to epilepsy.</article-title>
<source/><italic>Biochemistry</italic>
<volume>43</volume>
<fpage>7534</fpage>‚Äì<lpage>7540</lpage>. <pub-id pub-id-type="doi">10.1021/bi036181+</pub-id>
<pub-id pub-id-type="pmid">15182195</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinthaler</surname><given-names>E. M.</given-names></name><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Lal</surname><given-names>D.</given-names></name><name><surname>Semtner</surname><given-names>M.</given-names></name><name><surname>Merkler</surname><given-names>Y.</given-names></name><name><surname>Reinhold</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rare variants in gamma-aminobutyric acid type A receptor genes in rolandic epilepsy and related syndromes.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>77</volume>
<fpage>972</fpage>‚Äì<lpage>986</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24395</pub-id>
<pub-id pub-id-type="pmid">25726841</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Z.</given-names></name><name><surname>Sahir</surname><given-names>N.</given-names></name><name><surname>Murakami</surname><given-names>S.</given-names></name><name><surname>Luellen</surname><given-names>B. A.</given-names></name><name><surname>Earnheart</surname><given-names>J. C.</given-names></name><name><surname>Lal</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>88</volume>
<fpage>171</fpage>‚Äì<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.07.019</pub-id>
<pub-id pub-id-type="pmid">25107590</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>M.</given-names></name><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Levi</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Diffusion barriers constrain receptors at synapses.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e43032</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0043032</pub-id>
<pub-id pub-id-type="pmid">22912780</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>A. M.</given-names></name><name><surname>Richmond</surname><given-names>J. E.</given-names></name><name><surname>Olsen</surname><given-names>J. G.</given-names></name><name><surname>Hall</surname><given-names>D. H.</given-names></name><name><surname>Bamber</surname><given-names>B. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Presynaptic terminals independently regulate synaptic clustering and autophagy of GABAA receptors in <italic>Caenorhabditis elegans</italic>.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>1711</fpage>‚Äì<lpage>1720</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2279-05.2006</pub-id>
<pub-id pub-id-type="pmid">16467519</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>R. S.</given-names></name><name><surname>Kretschmannova</surname><given-names>K.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Activity-dependent phosphorylation of GABAA receptors regulates receptor insertion and tonic current.</article-title>
<source/><italic>EMBO J.</italic>
<volume>31</volume>
<fpage>2937</fpage>‚Äì<lpage>2951</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2012.109</pub-id>
<pub-id pub-id-type="pmid">22531784</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancar</surname><given-names>F.</given-names></name><name><surname>Czajkowski</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>A GABAA receptor mutation linked to human epilepsy (gamma2R43Q) impairs cell surface expression of alpha beta gamma receptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>47034</fpage>‚Äì<lpage>47039</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M403388200</pub-id>
<pub-id pub-id-type="pmid">15342642</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>M. J.</given-names></name><name><surname>Szent-Gyorgyi</surname><given-names>C.</given-names></name><name><surname>Fisher</surname><given-names>G. W.</given-names></name><name><surname>Jarvik</surname><given-names>J. W.</given-names></name><name><surname>Bruchez</surname><given-names>M. P.</given-names></name><name><surname>Waggoner</surname><given-names>A. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Fluorogen activating proteins in flow cytometry for the study of surface molecules and receptors.</article-title>
<source/><italic>Methods</italic>
<volume>57</volume>
<fpage>308</fpage>‚Äì<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2012.02.003</pub-id>
<pub-id pub-id-type="pmid">22366230</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Balsiger</surname><given-names>S.</given-names></name><name><surname>Bluethmann</surname><given-names>H.</given-names></name><name><surname>Mansuy</surname><given-names>I. M.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Mohler</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>24</volume>
<fpage>442</fpage>‚Äì<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1016/S1044-7431(03)00202-1</pub-id>
<pub-id pub-id-type="pmid">14572465</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>D.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Poduri</surname><given-names>A.</given-names></name><name><surname>Shiedley</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>De novo GABRG2 mutations associated with epileptic encephalopathies.</article-title>
<source/><italic>Brain</italic>
<volume>140</volume>
<fpage>49</fpage>‚Äì<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww272</pub-id>
<pub-id pub-id-type="pmid">27864268</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Q.</given-names></name><name><surname>Fuchs</surname><given-names>T.</given-names></name><name><surname>Sahir</surname><given-names>N.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e47441</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047441</pub-id>
<pub-id pub-id-type="pmid">23071808</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Q.</given-names></name><name><surname>Lal</surname><given-names>R.</given-names></name><name><surname>Luellen</surname><given-names>B. A.</given-names></name><name><surname>Earnheart</surname><given-names>J. C.</given-names></name><name><surname>Andrews</surname><given-names>A. M.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>68</volume>
<fpage>512</fpage>‚Äì<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.04.024</pub-id>
<pub-id pub-id-type="pmid">20579975</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>M. C.</given-names></name><name><surname>Ishii</surname><given-names>A.</given-names></name><name><surname>Yoshida</surname><given-names>S.</given-names></name><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Morita</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>55</volume>
<fpage>375</fpage>‚Äì<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2010.47</pub-id>
<pub-id pub-id-type="pmid">20485450</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>A. N.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Sarto-Jackson</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>14455</fpage>‚Äì<lpage>14468</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.165282</pub-id>
<pub-id pub-id-type="pmid">21343285</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>Y. M.</given-names></name><name><surname>Speer</surname><given-names>C. M.</given-names></name><name><surname>Babcock</surname><given-names>H. P.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Mapping synaptic input fields of neurons with super-resolution imaging.</article-title>
<source/><italic>Cell</italic>
<volume>163</volume>
<fpage>493</fpage>‚Äì<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.08.033</pub-id>
<pub-id pub-id-type="pmid">26435106</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigel</surname><given-names>E.</given-names></name><name><surname>Steinmann</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Structure, function, and modulation of GABA(A) receptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>40224</fpage>‚Äì<lpage>40231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R112.386664</pub-id>
<pub-id pub-id-type="pmid">23038269</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Scheffer</surname><given-names>I. E.</given-names></name><name><surname>Crossland</surname><given-names>K.</given-names></name><name><surname>Berkovic</surname><given-names>S. F.</given-names></name></person-group> (<year>1999</year>). <article-title>Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome.</article-title>
<source/><italic>Annu. Neurol.</italic>
<volume>45</volume>
<fpage>75</fpage>‚Äì<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8249(199901)45:1&lt;75::AID-ART13&gt;3.0.CO;2-W</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Davenport</surname><given-names>E. C.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Pathania</surname><given-names>M.</given-names></name><name><surname>Vaccaro</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>GIT1 and betaPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>9</volume>
<fpage>298</fpage>‚Äì<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.061</pub-id>
<pub-id pub-id-type="pmid">25284783</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>McAinsh</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Regulation of inhibitory synaptic transmission by a conserved atypical interaction of GABA(A) receptor beta- and gamma-subunits with the clathrin AP2 adaptor.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>55</volume>
<fpage>844</fpage>‚Äì<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.06.072</pub-id>
<pub-id pub-id-type="pmid">18662706</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>Y.</given-names></name><name><surname>Browarski</surname><given-names>M.</given-names></name><name><surname>Gruenig</surname><given-names>M. C.</given-names></name><name><surname>Sheehan</surname><given-names>D. F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Stabilization of GABA(A) receptors at endocytic zones is mediated by an AP2 binding motif within the GABA(A) receptor beta3 subunit.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>2485</fpage>‚Äì<lpage>2498</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1622-11.2011</pub-id>
<pub-id pub-id-type="pmid">22396422</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stojakovic</surname><given-names>A.</given-names></name><name><surname>Walczak</surname><given-names>M.</given-names></name><name><surname>Cieslak</surname><given-names>P. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Several behavioral traits relevant for alcoholism are controlled by 2 subunit containing GABAA receptors on dopamine neurons in mice.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>43</volume>
<fpage>1548</fpage>‚Äì<lpage>1556</lpage>. <pub-id pub-id-type="doi">10.1038/s41386-018-0022-z</pub-id>
<pub-id pub-id-type="pmid">29463910</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroligins and neurexins link synaptic function to cognitive disease.</article-title>
<source/><italic>Nature</italic>
<volume>455</volume>
<fpage>903</fpage>‚Äì<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1038/nature07456</pub-id>
<pub-id pub-id-type="pmid">18923512</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>SCN1A, SCN1B, and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>53</volume>
<fpage>769</fpage>‚Äì<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1007/s10038-008-0306-y</pub-id>
<pub-id pub-id-type="pmid">18566737</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szent-Gyorgyi</surname><given-names>C.</given-names></name><name><surname>Schmidt</surname><given-names>B. F.</given-names></name><name><surname>Creeger</surname><given-names>Y.</given-names></name><name><surname>Fisher</surname><given-names>G. W.</given-names></name><name><surname>Zakel</surname><given-names>K. L.</given-names></name><name><surname>Adler</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Fluorogen-activating single-chain antibodies for imaging cell surface proteins.</article-title>
<source/><italic>Nat. Biotechnol.</italic>
<volume>26</volume>
<fpage>235</fpage>‚Äì<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1368</pub-id>
<pub-id pub-id-type="pmid">18157118</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H. O.</given-names></name><name><surname>Reid</surname><given-names>C. A.</given-names></name><name><surname>Single</surname><given-names>F. N.</given-names></name><name><surname>Davies</surname><given-names>P. J.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Murphy</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>17536</fpage>‚Äì<lpage>17541</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0708440104</pub-id>
<pub-id pub-id-type="pmid">17947380</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenney</surname><given-names>J. R.</given-names></name><name><surname>Hopkin</surname><given-names>R. J.</given-names></name><name><surname>Schapiro</surname><given-names>M. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Deletion of 14-3-3{varepsilon} and CRK: a clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy.</article-title>
<source/><italic>J. Child Neurol.</italic>
<volume>26</volume>
<fpage>223</fpage>‚Äì<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1177/0883073810379638</pub-id>
<pub-id pub-id-type="pmid">20833799</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Jang</surname><given-names>I. S.</given-names></name><name><surname>Ha</surname><given-names>S. H.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Jovanovic</surname><given-names>J. N.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>GABAA receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>7074</fpage>‚Äì<lpage>7084</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1323-04.2004</pub-id>
<pub-id pub-id-type="pmid">15306641</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>The intronic <italic>GABRG2</italic> mutation, IVS6+2T-&gt;G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated gamma2 subunit.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>5937</fpage>‚Äì<lpage>5952</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5332-11.2012</pub-id><pub-id pub-id-type="pmid">22539854</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Mei</surname><given-names>D.</given-names></name><name><surname>Freri</surname><given-names>E.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Granata</surname><given-names>T.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Impaired surface alpha beta gamma GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>50</volume>
<fpage>135</fpage>‚Äì<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.10.008</pub-id>
<pub-id pub-id-type="pmid">23069679</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>C.</given-names></name><name><surname>Torrico</surname><given-names>B.</given-names></name><name><surname>Hervas</surname><given-names>A.</given-names></name><name><surname>Valdes-Mas</surname><given-names>R.</given-names></name><name><surname>Tristan-Noguero</surname><given-names>A.</given-names></name><name><surname>Padillo</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>784</fpage>‚Äì<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.106</pub-id>
<pub-id pub-id-type="pmid">23999528</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Pangalos</surname><given-names>M. N.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>1356</fpage>‚Äì<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5050-07.2008</pub-id>
<pub-id pub-id-type="pmid">18256255</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Kerschner</surname><given-names>B.</given-names></name><name><surname>Milenkovic</surname><given-names>I.</given-names></name><name><surname>Ramsden</surname><given-names>S. L.</given-names></name><name><surname>Ramerstorfer</surname><given-names>J.</given-names></name><name><surname>Saiepour</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Molecular basis of the gamma-aminobutyric acid A receptor alpha3 subunit interaction with the clustering protein gephyrin.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>37702</fpage>‚Äì<lpage>37711</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.291336</pub-id>
<pub-id pub-id-type="pmid">21880742</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Revilla-Sanchez</surname><given-names>R.</given-names></name><name><surname>Houston</surname><given-names>C.</given-names></name><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Havekes</surname><given-names>R.</given-names></name><name><surname>Florian</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Deficits in spatial memory correlate with modified {gamma}-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>20039</fpage>‚Äì<lpage>20044</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0908840106</pub-id>
<pub-id pub-id-type="pmid">19903874</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>W. C.</given-names></name><name><surname>Jenkins</surname><given-names>P. M.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Mooney</surname><given-names>R.</given-names></name><name><surname>Bennett</surname><given-names>V.</given-names></name></person-group> (<year>2015</year>). <article-title>Giant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>1214</fpage>‚Äì<lpage>1219</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1417989112</pub-id>
<pub-id pub-id-type="pmid">25552561</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twelvetrees</surname><given-names>A. E.</given-names></name><name><surname>Yuen</surname><given-names>E. Y.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>MacAskill</surname><given-names>A. F.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.</article-title>
<source/><italic>Neuron</italic>
<volume>65</volume>
<fpage>53</fpage>‚Äì<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.12.007</pub-id>
<pub-id pub-id-type="pmid">20152113</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezu</surname><given-names>A.</given-names></name><name><surname>Kanak</surname><given-names>D. J.</given-names></name><name><surname>Bradshaw</surname><given-names>T. W.</given-names></name><name><surname>Soderblom</surname><given-names>E. J.</given-names></name><name><surname>Catavero</surname><given-names>C. M.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Identification of an elaborate complex mediating postsynaptic inhibition.</article-title>
<source/><italic>Science</italic>
<volume>353</volume>
<fpage>1123</fpage>‚Äì<lpage>1129</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag0821</pub-id>
<pub-id pub-id-type="pmid">27609886</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Veen</surname><given-names>A. G.</given-names></name><name><surname>Ploegh</surname><given-names>H. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Ubiquitin-like proteins.</article-title>
<source/><italic>Annu. Rev. Biochem.</italic>
<volume>81</volume>
<fpage>323</fpage>‚Äì<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-093010-153308</pub-id>
<pub-id pub-id-type="pmid">22404627</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinkers</surname><given-names>C. H.</given-names></name><name><surname>Olivier</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators?</article-title>
<source/><italic>Adv. Pharmacol. Sci.</italic>
<volume>2012</volume>:<issue>416864</issue>. <pub-id pub-id-type="doi">10.1155/2012/416864</pub-id>
<pub-id pub-id-type="pmid">22536226</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vithlani</surname><given-names>M.</given-names></name><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Zhong</surname><given-names>P.</given-names></name><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Hines</surname><given-names>D. J.</given-names></name><name><surname>Revilla-Sanchez</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The ability of BDNF to modify neurogenesis and depressive-like behaviors is dependent upon phosphorylation of tyrosine residues 365/367 in the GABA(A)-receptor gamma2 subunit.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>15567</fpage>‚Äì<lpage>15577</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1845-13.2013</pub-id>
<pub-id pub-id-type="pmid">24068823</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wafford</surname><given-names>K. A.</given-names></name><name><surname>Burnett</surname><given-names>D. M.</given-names></name><name><surname>Leidenheimer</surname><given-names>N. J.</given-names></name><name><surname>Burt</surname><given-names>D. R.</given-names></name><name><surname>Wang</surname><given-names>J. B.</given-names></name><name><surname>Kofuji</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>1991</year>). <article-title>Ethanol sensitivity of the GABAA receptor expressed in <italic>Xenopus</italic> oocytes requires 8 amino acids contained in the gamma 2L subunit.</article-title>
<source/><italic>Neuron</italic>
<volume>7</volume>
<fpage>27</fpage>‚Äì<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(91)90071-7</pub-id>
<pub-id pub-id-type="pmid">1712603</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>R. H.</given-names></name><name><surname>Marini</surname><given-names>C.</given-names></name><name><surname>Petrou</surname><given-names>S.</given-names></name><name><surname>Harkin</surname><given-names>L. A.</given-names></name><name><surname>Bowser</surname><given-names>D. N.</given-names></name><name><surname>Panchal</surname><given-names>R. G.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>28</volume>
<fpage>49</fpage>‚Äì<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/88259</pub-id>
<pub-id pub-id-type="pmid">11326275</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Bedford</surname><given-names>F. K.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>1999</year>). <article-title>GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton.</article-title>
<source/><italic>Nature</italic>
<volume>397</volume>
<fpage>69</fpage>‚Äì<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/16264</pub-id>
<pub-id pub-id-type="pmid">9892355</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>D.</given-names></name><name><surname>Xia</surname><given-names>G.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Differential protein structural disturbances and suppression of assembly partners produced by nonsense GABRG2 epilepsy mutations: implications for disease phenotypic heterogeneity.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>35294</issue>. <pub-id pub-id-type="doi">10.1038/srep35294</pub-id>
<pub-id pub-id-type="pmid">27762395</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J. B.</given-names></name><name><surname>Burt</surname><given-names>D. R.</given-names></name></person-group> (<year>1991</year>). <article-title>Differential expression of two forms of GABAA receptor gamma 2-subunit in mice.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>27</volume>
<fpage>731</fpage>‚Äì<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1016/0361-9230(91)90054-N</pub-id>
<pub-id pub-id-type="pmid">1661635</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R. A.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Kolaj</surname><given-names>M.</given-names></name><name><surname>Randic</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Alpha-subunit of calcium/calmodulin-dependent protein kinase II enhances gamma-aminobutyric acid and inhibitory synaptic responses of rat neurons in vitro.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>73</volume>
<fpage>2099</fpage>‚Äì<lpage>2106</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1995.73.5.2099</pub-id>
<pub-id pub-id-type="pmid">7623101</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiting</surname><given-names>P.</given-names></name><name><surname>McKernan</surname><given-names>R. M.</given-names></name><name><surname>Iversen</surname><given-names>L. L.</given-names></name></person-group> (<year>1990</year>). <article-title>Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>87</volume>
<fpage>9966</fpage>‚Äì<lpage>9970</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.87.24.9966</pub-id>
<pub-id pub-id-type="pmid">1702226</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingrove</surname><given-names>P. B.</given-names></name><name><surname>Thompson</surname><given-names>S. A.</given-names></name><name><surname>Wafford</surname><given-names>K. A.</given-names></name><name><surname>Whiting</surname><given-names>P. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Key amino acids in the gamma subunit of the gamma-aminobutyric acidA receptor that determine ligand binding and modulation at the benzodiazepine site.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>52</volume>
<fpage>874</fpage>‚Äì<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1124/mol.52.5.874</pub-id>
<pub-id pub-id-type="pmid">9351978</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>P.</given-names></name><name><surname>Goetz</surname><given-names>T.</given-names></name><name><surname>Leppa</surname><given-names>E.</given-names></name><name><surname>Linden</surname><given-names>A. M.</given-names></name><name><surname>Renzi</surname><given-names>M.</given-names></name><name><surname>Swinny</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>923</fpage>‚Äì<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1038/nn1927</pub-id>
<pub-id pub-id-type="pmid">17572671</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>P.</given-names></name><name><surname>Ponomarenko</surname><given-names>A. A.</given-names></name><name><surname>Bartos</surname><given-names>M.</given-names></name><name><surname>Korotkova</surname><given-names>T. M.</given-names></name><name><surname>Fuchs</surname><given-names>E. C.</given-names></name><name><surname>Bahner</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>3561</fpage>‚Äì<lpage>3566</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0813176106</pub-id>
<pub-id pub-id-type="pmid">19204281</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>T.</given-names></name><name><surname>Hoyos-Ramirez</surname><given-names>E.</given-names></name><name><surname>Martenson</surname><given-names>J. S.</given-names></name><name><surname>Morimoto-Tomita</surname><given-names>M.</given-names></name><name><surname>Tomita</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>GARLH family proteins stabilize GABAA receptors at synapses.</article-title>
<source/><italic>Neuron</italic>
<volume>93</volume>
<fpage>1138</fpage>‚Äì<lpage>1152</lpage>.<issue>e6</issue>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.023</pub-id>
<pub-id pub-id-type="pmid">28279354</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Norris</surname><given-names>D.</given-names></name><name><surname>Tran</surname><given-names>D. D.</given-names></name><name><surname>Bram</surname><given-names>R.J.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA<sub>A</sub> receptors.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>38</volume>
<fpage>277</fpage>‚Äì<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2008.03.002</pub-id>
<pub-id pub-id-type="pmid">18424167</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zecharia</surname><given-names>A. Y.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Gotz</surname><given-names>T.</given-names></name><name><surname>Ye</surname><given-names>Z.</given-names></name><name><surname>Carr</surname><given-names>D. R.</given-names></name><name><surname>Wulff</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>13062</fpage>‚Äì<lpage>13075</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2931-12.2012</pub-id><pub-id pub-id-type="pmid">22993424</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Chakraborty</surname><given-names>S. K.</given-names></name><name><surname>Sampath</surname><given-names>P.</given-names></name><name><surname>Rojas</surname><given-names>J. J.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name><name><surname>Saurabh</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Fluoromodule-based reporter/probes designed for in vivo fluorescence imaging.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>3915</fpage>‚Äì<lpage>3927</lpage>. <pub-id pub-id-type="doi">10.1172/JCI81086</pub-id>
<pub-id pub-id-type="pmid">26348895</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Yoshida</surname><given-names>S.</given-names></name><name><surname>Migita</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>J.</given-names></name><name><surname>Mori</surname><given-names>F.</given-names></name><name><surname>Tomiyama</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Dysfunction of extrasynaptic GABAergic transmission in phospholipase C-related, but catalytically inactive protein 1 knockout mice is associated with an epilepsy phenotype.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>340</volume>
<fpage>520</fpage>‚Äì<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.111.182386</pub-id>
<pub-id pub-id-type="pmid">22128345</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Noviello</surname><given-names>C. M.</given-names></name><name><surname>Teng</surname><given-names>J.</given-names></name><name><surname>Walsh</surname><given-names>R. M.</given-names></name><name><surname>Kim</surname><given-names>J. J.</given-names></name><name><surname>Hibbs</surname><given-names>R. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Structure of a human synaptic GABAA receptor.</article-title>
<source/><italic>Nature</italic>
<volume>559</volume>
<fpage>67</fpage>‚Äì<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0255-3</pub-id>
<pub-id pub-id-type="pmid">29950725</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>